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DISCLAIMER 
 
This report or document ("the Report") is given by the Institute of Environmental Science and 
Research Limited ("ESR") solely for the benefit of the Ministry of Health, Public Health 
Service Providers and other Third Party Beneficiaries as defined in the Contract between ESR 
and the Ministry of Health, and is strictly subject to the conditions laid out in that Contract. 
 
Neither ESR nor any of its employees makes any warranty, express or implied, or assumes 
any legal liability or responsibility for use of the Report or its contents by any other person or 
organisation.    
 
To obtain permission to reuse or republish in any format material from this CISS annual 
report, please contact the Ministry of Health and ESR. 
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EXECUTIVE SUMMARY 
 
Current Situation 
 
• The Chemical Injury Surveillance System (CISS) presently incorporates national 
mortality data [sourced from the Coronial Services Office (CSO)], national inpatient 
hospitalisation data [sourced from the New Zealand Health Information Service 
(NZHIS)], national human exposure poisoning phone call data [sourced from the 
National Poisons Centre (NPC)], national spraydrift data [sourced from the DriftNet 
surveillance system], national chemical/poison related notifiable diseases data 
[sourced from EpiSurv, the National Notifiable Disease Database] and national 
accident claim data [sourced from the Accident Compensation Corporation (ACC)]. 
• CISS also incorporates local emergency department data notified to Public Health 
Units (PHUs).  Data received from PHUs for 2008 represent the following District 
Health Boards (DHBs): Waitemata, Auckland, Wairarapa, Capital and Coast, West 
Coast and Southland. 
• In December 2005, an amendment to the Hazardous Substances and New Organisms 
(HSNO) Act was made that now requires all diagnosing medical practitioners in 
addition to hospital practitioners to report injuries caused by hazardous substances to 
the Medical Officer of Health.  A case report form in EpiSurv to capture this data 
became operational on 19 September 2007. 
 
 
Results 
 
• National results for 2008: 
o 8571 poisoning hospitalisations (NZHIS), a national rate of 212.8 per 100 000 
population. 
o 22 755 NPC calls categorised as human poisonings. 
o 7 spraydrift complaints. 
o 1 chemical poisoning from the environment notification, no notifications of 
decompression sickness, 315 lead absorption notifications, 1 notification of 
toxic shellfish poisoning and 8 notifications of hazardous substances injury. 
o Approximately 506 claims to ACC relating to chemical and hazardous 
substances injury. 
o A HSNO substance was involved in 171 emergency department notifications 
involving approximately 51 substances, and 8 Hazardous Substances Injury 
notifications via EpiSurv involving 5 substances. 
 
 
• Waitemata DHB results for 2008: 
o 1159 poisoning hospitalisations (NZHIS), a rate of 240.7 per 100 000 
population. 
o 672 North Shore Hospital injury notifications, a rate of 139.5 per 100 000 
population 
 
Chemical Injury Surveillance for New Zealand, 2008  vii June 2009 
  
• Auckland DHB results for 2008: 
o 921 poisoning hospitalisations (NZHIS), a rate of 227.6 per 100 000 
population. 
o 2017 Auckland City Hospital injury notifications, a rate of 498.5 per 100 000 
population. 
 
• Wairarapa DHB results for 2008: 
o 120 poisoning hospitalisations (NZHIS), a rate of 310.4 per 100 000 
population. 
o 92 Masterton Hospital injury notifications, a rate of 238.0 per 100 000 
population. 
 
• Capital and Coast DHB results for 2008: 
o 215 poisoning hospitalisations (NZHIS), a rate of 80.6 per 100 000 population. 
o 563 Wellington Hospital injury notifications, a rate of 211.1 per 100 000 
population. 
 
• West Coast DHB results for 2008: 
o 46 poisoning hospitalisations (NZHIS), a rate of 146.8 per 100 000 population. 
o 5 Grey Hospital injury notifications, a rate of 16.0 per 100 000 population. 
 
• Southland DHB results for 2008: 
o 220 poisoning hospitalisations (NZHIS), a rate of 205.9 per 100 000 
population. 
o 163 Invercargill Hospital injury notifications, a rate of 152.6 per 100 000 
population. 
 
• Mortality data for 2006/2007 
o 196 chemical injury deaths in 2006 and 110 in 2007, as of 31 December 2008.  
Corresponding annual rates of 4.9 and 2.7 per 100 000 population, 
respectively. 
o Demographic and substance data were similar for both years. 
Chemical Injury Surveillance for New Zealand, 2008  1 June 2009 
  
1. INTRODUCTION 
 
In 2001, the Institute of Environmental Science and Research (ESR) was commissioned by 
the New Zealand Ministry of Health (MoH) to develop a national Chemical Injury 
Surveillance System (CISS).  The CISS was primarily developed in response to the legislative 
requirements of Section 143 of the Hazardous Substances and New Organisms (HSNO) Act 
(1996); all hazardous substance injuries that result in hospitalisation are to be notified to the 
Medical Officer of Health.  In December 2005, the HSNO Act was amended to include 
hazardous substance injury notifications from diagnosing medical practitioners. 
 
The CISS is intended to encompass this requirement, and extend it to achieve the greatest 
public health utility.  Hazardous substances incorporated in the CISS include substances not 
covered by the HSNO Act such as medicines in finished dose form, and party drugs or 
ethanol when classified as food (see also p.2).  Reporting to the CISS is not a legislative 
requirement, but it is one mechanism through which hospital and medical practitioners can 
meet their statutory obligations under the HSNO Act.  The following describes the objectives 
and scope of the CISS [adapted from previous ESR reports to the MoH (Bates & Fowles, 
2000; Fowles, 2001)], provides some definitions and discusses the current situation and other 
previously trialled approaches. 
 
 
1.1. Objectives of the CISS 
 
Two primary objectives are outlined below for the CISS: 
• National surveillance of chemical/hazardous substance injuries resulting in the review 
of appropriate controls for certain products, and areas for targeted intervention, 
including: restriction of access to methods of (para) suicide, reducing the number of 
childhood poisonings through reviewing child resistant packaging needs for certain 
products, and improving workplace practices leading to a reduced number of serious 
acute injuries from occupational settings 
• Improved local surveillance of chemical/hazardous substance injuries, by collecting 
specific data on substance/product, circumstances, and specific susceptible groups.  
The result being, the prioritisation of resources for facilitating investigations, 
intervention priorities and enforcement activities.   
 
1.2. Scope of the CISS 
1.2.1. Inclusions 
 
The system is intended to cover: 
• Injuries (for example, poisonings and chemical burns) caused by inappropriate use of 
hazardous substances including flammables and explosives 
• Injuries caused by inappropriate use of therapeutic substances and ethanol (when 
classified as food) 
• Poison/chemical related hospital admissions (including short stay unit admissions and 
presentations to emergency departments) 
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• Injuries from hazardous substances (under the HSNO Act) that result in a presentation 
to a medical practitioner (captured in EpiSurv as of 19 September 2007) 
• Fatalities where the primary cause of death was poison/chemical related 
• Both intentional and unintentional exposures 
• Chemical/poison related notifiable disease (non-biological). 
1.2.2. Exclusions 
 
The system is not intended to cover: 
• Adverse reactions to therapeutic agents when used as intended 
• Injuries or deaths where poisoning is a secondary cause (for example, car crashes) 
• Biological food poisonings (for example, salmonellosis). 
 
1.3. Definitions 
 
“Hospitalisation”:  The MoH has interpreted “hospitalisations” to include all hospital 
attendances, irrespective of whether the patient is classed as an inpatient or outpatient.  The 
MoH considers the distinction between overnight stays and brief stays to be irrelevant, but 
considers that the important element is whether the person was treated as a patient. 
 
“Hazardous substance”:  The HSNO Act defines a hazardous substance as a substance 
which possesses an intrinsic toxicity, ecotoxicity, flammability, capacity to oxidise, having an 
explosive, or corrosive property that meet pre-defined thresholds set by the Environmental 
Risk Management Authority New Zealand (ERMANZ) (Environmental Risk Management 
Authority New Zealand, 2008).  Certain substances are excluded from ERMA’s jurisdiction 
even though they are clearly hazardous under the definition of the Act - this is because they 
are regulated under different legislation.  Examples of these substances include human 
therapeutic drugs in finished form (which are regulated under the Medicines Act) and ethanol 
(alcohol) when classified as a food (which is regulated under the Food Act).  These 
substances are often referred to as ‘non-hazardous, for the purposes of the HSNO Act’.  Since 
the CISS is an instrument of the MoH, and is driven by a public health need, the substances 
included in it extend beyond that defined by ERMA’s regulatory limits.  This is why 
therapeutic drugs and alcohol are included in the system, even though they are not regulated 
by the HSNO Act per se.   
 
“Injury”:  Has been defined by the MoH as any physical harm or damage serious enough to 
warrant medical treatment. 
 
“Primary Substance”: the primary substance identified that was involved in the death, it 
does not infer it is necessarily the single causative substance. 
 
Substance Classes, for example chemicals/drugs of abuse:  refer to Appendix 2. 
 
1.4. Current Situation 
 
Figure 1 presents a summary of the evolution of the New Zealand Chemical Injury 
Surveillance System.   
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Since 2001, three approaches for obtaining hospital notification data have been trialled and/or 
assessed.  The latest, successfully trialled for Auckland in 2003 was a ‘comprehensive’ 
surveillance system incorporating injury data from the NZHIS, NPC, CSO and PHU.  Results 
of this trial were presented in a report to the MoH in December 2003 (McDowell, Fowles, & 
Phillips, 2003). 
 
Despite encountering some concerns, the trial was able to provide better functional analyses 
for local investigation and intervention, as well as national policy and practice, than other 
systems trialled to date.  Specifically, the information provided by each data set could be used 
to better understand the underlying causes and consequences of exposures to hazardous 
substances.   
 
Figure 2 is known as the injury pyramid; it demonstrates the relationship between severity of 
injury and the number of injuries that occur.  For example, the peak of the injury pyramid 
represents fatal injuries, these are fewer in number but are highly visible, conversely, the base 
of the pyramid depicts injuries that do not receive attention in a health care institution; this 
represents the greatest number of injuries.  The CSO mortality data, NZHIS inpatient 
hospitalisation data, PHU hospital emergency department data, NPC data, DriftNet spraydrift 
complaint data, EpiSurv chemical/poison related notifiable disease data and medical 
practitioner HSNO notifications, and ACC claim data, therefore cover a wide spectrum of the 
injury pyramid. 
 
 
Figure 2:  The Injury Pyramid.  Adapted from: (Espitia-Hardeman & Paulozzi, 2005)   
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During the 2003/04 financial year, it was proposed that the ‘comprehensive’ system be 
implemented as the national chemical injuries surveillance system and roll-out of the system 
take place during this period.  A report prepared for the MoH addressing this implementation 
and 2003 statistics was released in June 2004 (McDowell, Fowles, & Phillips, 2004) and a 
report on 2004 statistics was released in July 2005 (McDowell & Gallagher, 2005).  The 
launch of the case report form for hazardous substance injury notifications via EpiSurv in 
September 2007 will ensure that all sectors of the injury pyramid (with the exception of 
injuries that do not receive medical attention which is virtually impossible to collect) will be 
captured by the CISS. 
 
Previous to 1 July 2007, deaths were investigated under the Coroners Act 1988 and coronial 
files were stored at the CSO.  Deaths investigated post 1 July 2007 are now to be accessed 
through the Coronial Services Case Register and external access to, and extraction from, this 
register is under review by the CSO.  The case register is an interim solution pending the 
design and installation of any new database.  The CISS can continue to collect data for deaths 
that occurred before 1 July 2007, and ESR will continue to liaise with personnel from the 
CSO in regard to future data provision for deaths occurring post 1 July 2007.  For this reason, 
completeness of CSO mortality data for 2007 is likely to be approximately 50-60% of those 
that are usually estimated, as only deaths prior to 1 July 2007 were able to be obtained. 
 
During 2007 a review of the International Classification of Disease (ICD) version 10 (ICD-
10) external cause codes incorporated in the CISS was undertaken.  As a result, the list of 
codes has been expanded to be more comprehensive of the range of chemical and hazardous 
substances injuries that occur.  The current codes can be found in Table 1. 
 
From 2007 two additional data types are included in the CISS; ACC data and summarised 
media data.  With respect to the medium term strategy more details are given in Section 3 of 
this report. 
 
A brief overview on the comprehensive surveillance system and the specific datasets are 
given in Section 2 of this report. 
 
 
1.5. Other Approaches Trialled to Date 
 
Prior to the comprehensive CISS, two other approaches were investigated: a) a paper and 
email based system and b) an electronic system.  As further details on the first are given in a 
2002 MoH report (Fowles et al., 2002) and details on both are given in the 2003 MoH report 
(McDowell et al., 2003), only a brief overview is given here. 
 
 
1.5.1. Paper and Email Based System 
• Trialled July-December 2001 in six PHUs. 
• Modelled on the national notifiable disease system (EpiSurv). 
• Level of notification varied greatly from region to region with only one (smaller) 
region providing sufficient data for subsequent analysis. 
• Number of issues, principally time to complete paper forms. 
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1.5.2. Electronic System 
• Electronic transfer of details from the hospital system. 
• Cases to be identified based on ICD-10 codes. 
• Discussion held regarding trialling at Middlemore Hospital but data fields which could 
be obtained without significant additional funding would not differ to that sent to 
NZHIS as part of the National Minimum Data Set. 
• Nationwide hospital survey indicated that the system could work but would require 
information technology changes to existing patient management systems (this would 
involve set up costs and/or ongoing funds). 
• Thus with appropriate funding, an electronic system could potentially be implemented 
as hospitals update and renew their patient management systems. 
 
 
1.6. Incorporation of the Email and Electronic Based Approaches into the 
Comprehensive Surveillance System 
 
While not relying solely on PHU notification data to obtain a picture of the burden of disease 
from chemical injuries, the comprehensive system does incorporate data from this source. 
 
Experiences with the paper based and electronic systems showed that no one approach would 
work in all settings and that local circumstance would dictate local data quality and capture 
practicalities.  
 
 
1.7. This Report 
 
This report provides a brief overview of the comprehensive surveillance system before 
detailing its continuation during the 2008/2009 financial year.  Summary statistics from the 
various data sources for 2008 are then presented as are additional CSO analyses pertaining to 
2006 and 2007.  The Coronial Services Office is currently migrating files to a new electronic 
system so it is not possible to access files for deaths post 1 July 2007.  Therefore mortality 
data cannot be examined for 2008 and only six months of data is included in the 2007 
analysis. 
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2. BACKGROUND OF THE COMPREHENSIVE CHEMICAL INJURY 
SURVEILLANCE SYSTEM 
 
2.1. Introduction 
 
A brief overview of the comprehensive system is given below. More detail can be sourced 
from the 2003 MoH report (McDowell et al., 2003). 
• Different health exposures and injuries result in different contacts with the health 
system, for example, some injuries may be attended to in the home, others would 
involve a visit to a General Practitioner and/or be hospitalised.  Some health exposures 
and injuries may ultimately result in death with or without receiving medical attention. 
Data from several sources are therefore required to develop a comprehensive 
surveillance system. 
• By implementing a surveillance system which encompasses several health outcomes 
(as opposed to just hospital morbidity for example) in addition to exposure and hazard 
data, a more complete picture of heath effects resulting from exposure to hazardous 
substances/chemicals can be achieved (Figure 2).  
• The following data sources are incorporated into the comprehensive surveillance 
system: Coronial Services Office, New Zealand Health Information Service, Public 
Health Units, the National Poisons Centre, DriftNet, EpiSurv and Accident 
Compensation Corporation.  
 
2.2. Coronial Services Office Data 
 
• All deaths that result from acute chemical injury are deemed to be suspicious; 
therefore, a coroner’s inquest should be completed.  
• Files are stored at the national CSO in Wellington. 
• Case demographics, circumstances surrounding death (including intent), and 
toxicology results are available from CSO files.  
• Although initially obtained manually, ESR now receives most of this data 
electronically. ESR has been receiving CSO data since 2001. 
• The main limitation associated with the coronial data is timeliness.  It is estimated that 
by the end of a given year, approximately 50-60% of cases for that year are available. 
By the end of the following year, it is estimated that 90-95% of cases for the preceding 
year will have files readily accessible.  
• The small number of chemical injury deaths means caution should be exercised when 
interpreting data, especially rates. 
 
2.3. New Zealand Health Information Service Data 
 
• Public hospitals are required to provide NZHIS with data known as the National 
Minimum Data Set (NMDS) for all inpatients (those admitted to hospital. Note that 
the criteria for classification as an inpatient differs between hospitals). 
Chemical Injury Surveillance for New Zealand, 2008 8 June 2009 
  
• Hospitalisations with International Classification of Disease (ICD) version 10 (ICD-
10) external cause codes of interest (Table 1) are identified and the relevant data 
obtained from NZHIS.  
• Data includes basic demographics, domicile code, admission and discharge date, ICD-
10 codes (external cause codes and diagnosis codes) and free text fields.  
Table 1:  ICD-10 External Causes of Morbidity Codes of Interest for Chemical Injury Surveillance 
ICD-10 Code Description 
Intentional poisoning by and exposure to: 
X60 Nonopioid analgesics, antipyretics and antirheumatics 
X61 
Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere 
classified 
X62 Narcotics and psychodysleptics [hallucinogens], not elsewhere classified 
X63 Other drugs acting on the autonomic nervous system 
X64 Other and unspecified drugs, medicaments and biological substances 
X65 Alcohol 
X66 Organic solvents and halogenated hydrocarbons and their vapours 
X67 Other gases and vapours 
X68 Pesticides 
X69 Other and unspecified chemicals and noxious substances 
X75 Intentional self-harm by explosive material 
X76 Intentional self-harm by smoke, fire and flames 
X83 Intentional self-harm by other specified means 
Unintentional poisoning by and exposure to: 
X40 Nonopioid analgesics, antipyretics and antirheumatics 
X41 
Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere 
classified 
X42 Narcotics and psychodysleptics [hallucinogens], not elsewhere classified 
X43 Other drugs acting on the autonomic nervous system 
X44 Other and unspecified drugs, medicaments and biological substances 
X45 Alcohol 
X46 Organic solvents and halogenated hydrocarbons and their vapours 
X47 Other gases and vapours 
X48 Pesticides 
X49 Other and unspecified chemicals and noxious substances 
Poisoning by and exposure to (undetermined intent): 
W36 Explosion and rupture of gas cylinder 
W37 Explosion and rupture of pressurized tyre, pipe or hose 
W38 Explosion and rupture of other specified pressurized devices 
W39 Discharge of firework 
W40 Explosion of other materials 
X04 Exposure to ignition of highly flammable material 
X08 Exposure to other specified smoke, fire and flames 
X20 Contact with venomous snakes and lizards 
X21 Contact with venomous spiders 
X22 Contact with scorpions 
X23 Contact with hornets, wasps and bees 
X24 Contact with centipedes and venomous millipedes (tropical) 
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X25 Contact with other venomous arthropods 
X26 Contact with venomous marine animals and plants 
X27 Contact with other specified venomous animals 
X28 Contact with other specified venomous plants 
X58 Exposure to other specified factors 
Y25 Contact with explosive material 
Y26 Exposure to smoke, fire and flames 
Y33 Other specified events 
Y86 Sequelae of other accidents 
Y870 Sequelae of intentional self-harm, assault and events of undetermined intent 
Y872 Sequelae of events of undermined intent 
Y10 Nonopioid analgesics, antipyretics and antirheumatics 
Y11 
Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere 
classified 
Y12 Narcotics and psychodysleptics [hallucinogens], not elsewhere classified 
Y13 Other drugs acting on the autonomic nervous system 
Y14 Other and unspecified drugs, medicaments and biological substances 
Y15 Alcohol 
Y16 Organic solvents and halogenated hydrocarbons and their vapours 
Y17 Other gases and vapours 
Y18 Pesticides 
Y19 Other and unspecified chemicals and noxious substances 
Assault 
X85 Assault by drugs, medicaments and biological substances 
 X86 Assault by corrosive substance 
X87 Assault by pesticides 
X88 Assault by gases and vapours 
X89 Assault by other specified chemicals and noxious substances 
X96 Assault by explosive material 
X97 Assault by smoke, fire and flames 
Y08 Assault by other specified means 
Y871 Sequelae of assault 
Legal intervention 
Y351 Legal intervention involving explosives 
Y352 Legal intervention involving gas 
 Y356 Legal intervention involving other specified means 
Y890 Sequelae of legal intervention 
 
Limitations associated with the NZHIS data: 
o Only inpatients are captured, therefore those treated in emergency departments but 
not admitted are not included 
o Criteria for classification as an inpatient vary between hospitals 
o Often, only generic classification of the substances involved is available, rather than 
the specific substance name 
o There is a time delay between presentation at hospital and availability of the data 
from NZHIS. This varies by area, but is generally less than one year 
o The ICD-10-AM coding system is complex and inflexible.  The current version is 
the 10th since ICD coding was first used in 1901. 
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2.4. Public Health Unit Data 
 
• While a paper and email-based system piloted in 2001 was not universally successful, 
some PHUs currently operate their own local surveillance systems based on this 
approach.  
• Any data, whether collected via a paper or electronic system can be incorporated into 
the comprehensive CISS.  
• The quality, completeness and consistency of data collected vary between PHUs.  
Classification of intent can be problematic. 
 
2.5. National Poisons Centre Data 
 
• The NPC operates a 24 hours a day, 365 days per year telephone service that fields 
enquiries regarding actual or potential toxic exposures.  
• While there is no requirement to phone the NPC in the event of a poisoning, about    
32 000 phone calls are received each year.  
• Details of calls are recorded in an electronic database. 
• NPC also operates an Internet database known as TOXINZ. 
• There is no clinical or laboratory confirmation of actual exposures. 
  
2.6. DriftNet (Spraydrift) Data 
 
• DriftNet is a surveillance system designed to monitor the incidence of spraydrift 
events with potential, reported or alleged health effects.   
• Sourced from PHU staff who collect information on spraydrift complaints and 
incidents that are reported to them. 
• Comparison with regional council data indicates that the DriftNet system is under 
utilised. 
 
2.7. Chemical/Poison Related Notifiable Disease Data 
 
• A number of chemical/poison related diseases are currently notifiable under the Health 
Act (1956). 
• Sourced from EpiSurv – the national notifiable disease surveillance system. 
• Diseases of interest include: decompression sickness, chemical poisoning from the 
environment, lead absorption, toxic shellfish poisoning and hazardous substances 
injury (hazardous substances injury is notifiable under the HSNO Act).  
• As with communicable diseases there is likely to be a degree of under-reporting of 
chemical/poison related diseases.  The extent to which the data reflect the true 
incidence of the disease burden is affected by many factors such as: public awareness 
of the injury, use of diagnostic facilities and the interest, resources and priorities of 
local public health units (see Institute of Environmental Science and Research, 2008 
for a discussion of under reporting). 
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2.8. Accident Compensation Corporation claim data 
 
• The ACC administers New Zealand’s accident compensation scheme, which provides 
personal injury cover for all New Zealand citizens, residents and temporary visitors to 
New Zealand. 
• ACC is a crown entity and is responsible for many things including: paying 
compensation, buying health and support services to treat and care for injured people 
and providing injury prevention services. 
• Data collected on accident compensation claims include demographics, ICD-10 
diagnosis codes (external cause codes not assigned) and geographic details.  
Unfortunately not all claims are assigned an ICD-10 code and it is not possible to find 
out what proportion of claims this relates to.  Where numbers of claims are less than 
or equal to three, the exact figure cannot be provided.  For these reasons, when 
referring to ACC claim data in this report, the figures are often referred to as 
estimates.   
 
 
 
Chemical Injury Surveillance for New Zealand, 2008 12 June 2009 
  
3. PROGRESS ON NATIONAL IMPLEMENTATION AND DEVELOPMENT OF 
THE MEDIUM TERM STRATEGY, 2008/2009 
 
National implementation of the comprehensive surveillance system was initiated in 
2003/2004 following the successful pilot for the Auckland region.  National data continues to 
be received on a quarterly basis from the NZHIS for inpatient hospitalisations and from the 
CSO for fatal chemical injury cases (note figures are not available for deaths post 1 July 
2007).  CISS datasets from these sources date back to 2001.  National DriftNet (spraydrift) 
data date back to 1998.  From 2006, the CISS will also be reporting on a number of 
chemical/poison related notifiable diseases from EpiSurv.  National NPC data for the period 
January to December 2007 was obtained for the first time in electronic format, and was 
available again for the year 2008. 
 
Local chemical injury emergency department notifications from Auckland Regional Public 
Health Service (ARPHS) for Auckland City Hospital, and West Coast Public Health Unit 
(WCPHU) for Grey Hospital, also continue to be received on a regular basis.  Datasets for 
both date back to 2003.  The CISS also includes local injury notification data from Southland 
Public Health Unit (SOPHU) for Invercargill Hospital, for the years 2002-2008 and Regional 
Public Health (RPH) representing Capital and Coast DHB (Wellington Hospital) for the years 
2005-2008.  North Shore and Waitakere Hospital emergency department notifications are 
incorporated for the first time in this report for the year 2008.  From 2004-2005 the CISS also 
incorporated data representing Hutt Valley DHB (this was not available for 2006-2008) and 
Wairarapa DHB for the years 2004-2006 and 2008 (Masterton Hospital data not available for 
2007).   
 
Thus this report is able to document injury trends for the above six DHBs.  The contributing 
DHBs are well representative of New Zealand, both on a geographic and population basis.  
Four of the six DHBs are based in the North Island, most of which represent large 
metropolitan centres.  On a DHB population basis Waitemata is ranked first, Auckland DHB 
is ranked fourth, Capital and Coast is ranked sixth, and Wairarapa is ranked twentieth out of 
all 21 DHBs.  The other two DHBs represent smaller provincial and rural areas in the South 
Island.  West Coast has the smallest population of all the DHBs and Southland is ranked 
14/21.  This cross-section of DHBs provides a useful sentinel surveillance system, which 
incorporated with the national datasets, provides useful analysis that can contribute to the 
planning and implementation of policies and interventions. 
 
However, the nature of the CISS is such that new datasets can be readily incorporated.  
Sourcing of further PHU/emergency department data continues and will be integrated when 
available, for example North Shore/Waitakere Emergency Department data for 2008. 
 
The 2006 Annual CISS Report was the first time that a number of chemical/poison related 
notifiable diseases (under the Health Act) were incorporated.  This adds another dimension to 
the comprehensive CISS and continues for the 2008 analysis.  The chemical/poison related 
notifiable diseases (with the exception of hazardous substance injuries) will continue to be 
reported in the “Notifiable and Other Diseases in New Zealand Annual Report” (for example 
Institute of Environmental Science and Research, 2008). 
 
A new notifiable disease that was incorporated in the 2007 Annual CISS Report was 
hazardous substances injury notifications from medical practitioners.  In December 2005, an 
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amendment to the HSNO Act was made that now requires all diagnosing medical 
practitioners, in addition to hospitals, to report injuries caused by hazardous substances to the 
Medical Officer of Health.  However, the notification of diseases from substances not 
classified as hazardous substances is still not mandated.  This would require changes to 
legislation outside of the HSNO Act, for example, the Health Act.  A case report form for 
capturing hazardous substances injury notifications was incorporated into EpiSurv on 19 
September 2007.   
 
Under the Health Act, clinicians are required to notify certain scheduled medical diseases to 
the Medical Officer of Health.  As of December 2007, laboratories are now required to report 
test results that indicate a person is or may be infected with a notifiable disease or illness to 
the Medical Officer of Health  (Ministry of Health, 2007).  The new legislative requirements 
will improve the old system and will lead to improvements in the rates of reporting.  This is 
unlikely to impact on the 2007 CISS Annual Report numbers and rates and may lead to an 
increase in the numbers of notifiable diseases reported from 2008 onwards as has been noted 
for lead absorption. 
 
As recognised for several years, the most desirable means of capturing any notification data is 
via integration with patient management systems.   ESR continues to investigate the potential 
of providing a web based reporting tool for direct reporting of notifications from medical 
practitioners. If a system is developed this could be expanded to include direct reporting from 
hospitals and medical practitioners for notifications of hazardous substance injuries. The 
major complication with this approach is that no one common patient management system is 
used by all hospitals, and even within the same hospital a different system may be used for 
emergency department patients and inpatients.  Furthermore, General Practitioners use 
different systems again.  Thus to have a nationwide integrated system would involve funding 
which is not presently available.  With respect to the CISS, until a system is in place we will 
continue to seek permission to obtain emergency department electronic data extracts from 
those hospitals not currently covered by the CISS. 
 
DriftNet data continue to be included in this report but as in previous years, the numbers of 
reported events are low.  Comparison with regional council data indicates that the DriftNet 
system (employed in PHUs) is under-utilised.  Therefore improved communication between 
regional councils and PHUs may enhance the referral of spraydrift incidents with health 
impacts to PHUs. 
 
An additional data set which was incorporated for the first time in the 2007 CISS Annual 
Report is claim data from the ACC.  Although the data summarised in this report is not a true 
reflection of claims relating to chemical injury (due to issues surrounding data collection and 
provision, including: many of the claims do not have ICD codes, the ones that do have ICD 
codes only have the diagnosis code and not the external cause code, codes with a small 
number of claimants undergo rounding and it is not possible to analyse each claim 
individually, they are only aggregated to a larger grouping), it provides trends which highlight 
the number of people who have injuries from chemicals and hazardous substances that are 
severe enough to warrant accident compensation.  The number reported here is therefore an 
under-representation of the true figure. 
 
The 2007 CISS Annual Report was also the first time a summary media analysis was included 
and this is again incorporated.  It is apparent that many chemical/poison related notifiable 
illnesses are reported in the media, of which a minority are reported to EpiSurv.  A short 
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summary is included in this annual report to highlight the types of poison/chemical injuries 
that are reported in the media. 
 
In 2006/2007, an internal review of the CISS was carried out by the CISS team to provide the 
MoH with a number of recommendations for enhancing the surveillance system.  With respect 
to strategies listed in the 2006 CISS Annual Report (Tisch & Slaney, 2007) to be carried out 
in 2008/2009 these have been addressed.  The CISS now receives ICD diagnosis codes and 
free text fields, and the development of automated search algorithms for extracting further 
substance information was completed in 2008. 
 
In 2008/2009, further strategies that were developed include:  
• Continue to investigate the potential of providing a web based reporting tool for 
hospitals and medical practitioners for directly notifying PHUs and ESR (on behalf of 
the MoH) of incidents of hazardous substances injuries. 
 
Since 2005, ESR has invested $1.5M in the development of an information integration 
platform, SurvINZ, with a redevelopment of the pre-existing national notifiable disease 
surveillance system (EpiSurv 6) to a web based national surveillance system (EpiSurv). This 
has enabled the integration of systems such as direct laboratory notification.   
 
In the Direct Laboratory Notification Project, the MoH has overseen the communications with 
PHUs and laboratories, the development of HL7 data standards (ENDMS Guide), security and 
data transmission mechanisms.  ESR has configured specialist software as the message 
receiver or “message broker” to the ENDMS guide and made the appropriate changes in 
EpiSurv to ensure there is a PHU user interface for the DLNP.  The system, LabSurv, has 
been configured to two HL7 standards (2.1 and 2.4). 
  
Theoretically the mechanism now exists for the direct reporting of hazardous substance 
injuries by hospitals and medical practitioners to PHUs and ESR (on behalf of the Ministry of 
Health).  The next challenge in the process is the engagement of hospitals and medical 
practitioners. This will require political commitment and a well planned careful consultation 
process with the parties involved.  
 
Although the CISS covers the majority of data sources explained in the injury pyramid 
(Figure 2), it is recognised that some of the data sources are not complete (for example, 
emergency department notifications are only received from six hospitals, and a degree of 
under-reporting exists for spraydrift complaint and EpiSurv notifiable disease data).  Given 
that the intent of the CISS is to examine mortality and morbidity associated with hazardous 
substances injuries in New Zealand, there is potential to look at additional or alternative 
surveillance methods for obtaining such data.  In the future other techniques could be 
employed such as sentinel surveys of general and hospital based practitioners.   
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4. RESULTS FROM THE CHEMICAL INJURIES SURVEILLANCE SYSTEM 
FOR 2008 
 
 
4.1. Introduction 
 
National results for 2008 are presented for the NZHIS hospitalisation data by DHB, age, sex, 
ethnicity, intent and substance.  Summarised results for spraydrift complaints, 
chemical/poison related notifiable diseases, National Poisons Centre call data, Accident 
Compensation Corporation data and a media analysis follow.  A more detailed analysis of the 
combined datasets relating to injuries in children aged less than five years, poisonings 
involving paracetamol and ethanol, and injuries caused by substances covered by the HSNO 
Act are then discussed.  Finally, results from the CSO data for the years 2006 and 2007 are 
documented.  As mentioned earlier in this report, mortality data for those who died post 1 July 
2007 is unavailable.  This report uses 2006 census data and prioritised ethnicity to calculate 
rates.   
 
 
4.2. Summary of Key Statistics  
 
4.2.1. National Analysis 
• See Appendix 1 Table 6, Table 7 and Table 14. 
• 8571 poisoning hospitalisations (NZHIS) in 2008, a national rate of 212.8 per 100 000 
population. 
• 22 755 NPC calls categorised as human poisoning for 2008. 
• 7 spraydrift complaints in 2008. 
• 1 chemical poisoning from the environment notification, no notifications of 
decompression sickness, 315 lead absorption notifications, 1 cases of toxic shellfish 
poisoning and 8 cases of hazardous substance injury were reported for 2008.   
• Wairarapa DHB had the highest NZHIS poisoning hospitalisation rates (310.4 per 
100 000, 120), with the lowest rate recorded from Capital and Coast DHB (80.6 per 
100 000 population, 215).   
• The majority of the NZHIS poisoning hospitalisations (48.7%, 4177) were deemed 
intentional (however 1690 were of unknown intent). 
• The highest age-specific rate for the NZHIS data was for those aged 15-24 years 
(369.2 per 100 000 population, 2109). 
• The majority of the NZHIS hospitalisations were female (57.7%, 4946). 
• Where ethnicity was known, the majority of NZHIS hospitalisations (71.3%, 
6042/8480) were for Europeans.  Maori had the highest NZHIS hospitalisation rate 
(256.0 per 100 000 population, 1447). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (24.5%, 2102), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(12.9%, 1107).  Of the X61 poisonings where substance was known (1200 poisonings 
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and 1489 substances, note some poisonings had more than one substance listed), the 
most common substance was zopiclone (21.0%, 313/1489), followed by quetiapine 
(12.5%, 186) and citalopram (7.7%, 114). 
• The most common substance identified in the NPC human exposure call data was 
paracetamol (5.4%, 1230/22 646), followed by dishwashing liquid (2.8%, 640) and all 
purpose cleaner (2.4%, 547). 
 
 
4.2.2. Waitemata DHB Analysis 
• See Appendix 1 Table 6, Table 8 and Table 15. 
• 1159 NZHIS hospitalisations, a rate of 240.7 per 100 000 population. 
• 672 North Shore/Waitakere Hospital injury notifications, a rate of 139.5 per 100 000 
population. 
• 2240 NPC human exposure calls, a rate of 465.1 per 100 00 population. 
• The majority of North Shore Hospital notifications (44.3%, 298) and NZHIS 
hospitalisations were intentional (51.1%, 592). 
• The 15-24 years age group had the highest notification rate (353.0 per 100 000 
population, 239) and NZHIS hospitalisation rate (443.1 per 100 000 population, 300). 
• The majority of notification data (58.4%, 392) and NZHIS hospitalisations were for 
females (56.9%, 660). 
• Where ethnicity was known, the majority of notifications (78.4%, 515/657) and 
NZHIS hospitalisations (74.4%, 855/1149) were for Europeans.  Europeans had the 
highest ethnicity-specific notification rate (163.4 per 100 000 population) and Maori 
had the highest ethnic-specific NZHIS hospitalisation rate (314.9 per 100 000 
population, 135).  
• Where substance was known (564), the most common substance was ethanol (40.6%, 
229), followed by paracetamol (18.1%, 102) and zopiclone (5.1%, 29). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (26.8%, 311), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(13.2%, 153).  Of the X61 poisonings where substance was known (157 poisonings 
and 218 substances, note some poisonings had more than one substance listed), the 
most common substance was zopiclone (22.5%, 49/218), followed by quetiapine 
(12.4%, 27) and citalopram (8.3%, 18). 
 
4.2.3. Auckland DHB Analysis 
• See Appendix 1 Table 6, Table 9 and Table 16. 
• 921 NZHIS hospitalisations, a rate of 227.6 per 100 000 population. 
• 2017 Auckland City Hospital injury notifications reported to ARPHS, a rate of 498.5 
per 100 000 population. 
• 2277 NPC human exposure calls, a rate of 562.8 per 100 000 population. 
• The majority of ARPHS notifications were of unknown intent (93.3%, 1882) and the 
majority of NZHIS hospitalisations were intentional (54.0%, 497). 
• The 15-24 years age group had the highest ARPHS age-specific notification rate 
(1180.9 per 100 000 population, 794) and NZHIS hospitalisation rate (358.4 per     
100 000 population, 241). 
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• The majority of ARPHS notification data was for males (55.5%, 1112); however, the 
majority of NZHIS hospitalisation data was for females (55.9%, 515). 
• Where ethnicity was known, the majority of ARPHS notifications (68.7%, 1339/1948) 
and NZHIS hospitalisations (64.3%, 581/904) were for Europeans.  Maori had the 
highest ethnic-specific ARPHS notification rate (690.3 per 100 000 population, 206) 
and NZHIS hospitalisation rate (361.9 per 100 000 population, 108). 
• Where substance was known (2756), the most common ARPHS substance was ethanol 
(53.0%, 1460), followed by paracetamol (5.3%, 146) and zopiclone (3.9%, 107). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (27.3%, 251), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(15.4%, 142).  Of the X61 poisonings where substance was known (218 poisonings 
and 280 substances, note some poisonings had more than one substance listed), the 
most common substance was zopiclone (22.9%, 64/280), followed by quetiapine 
(10.4%, 29) and citalopram (8.2%, 23). 
 
4.2.4. Wairarapa DHB Analysis 
• See Appendix 1 Table 6, Table 10 and Table 17. 
• 120 NZHIS hospitalisations, a rate of 310.4 per 100 000 population. 
• 92 Masterton Hospital injury notifications reported to RPH, a rate of 238.0 per        
100 000 population. 
• 177 NPC human exposure calls, a rate of 457.9 per 100 000 population. 
• The majority of RPH notifications and NZHIS hospitalisations were intentional 
(62.0%, 57 and 55.0%, 66, respectively).  
• The 0-4 years age group had the highest RPH age-specific rate (574.0 per 100 000 
population, 14) and the 15-24 years age group had the highest NZHIS age-specific rate 
(780.1 per 100 000 population, 33). 
• The majority of RPH notifications (60.9%, 56) and NZHIS hospitalisations (55.0%, 
66) were females. 
• The majority of RPH notifications (76.7%, 56/73) and NZHIS hospitalisations (75.8%, 
91) were for Europeans, and the highest ethnic-specific rate was for Maori (273.1 per 
100 000 population, 15; 455.2 per 100 000 population, 25, respectively).   
• Where substance was known (125), the most common RPH substance was ethanol 
(20.0%, 25), followed by paracetamol (11.2%, 14) and zopiclone (8.0%, 10). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (23.3%, 28), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(15.0%, 18).  Of the X61 poisonings where substance was known (10 poisonings and 
11 substances, note one poisoning had two substances listed), the most common 
substance was zopiclone (27.3%, 3/11), followed by citalopram and 
methotrimeprazine (for each: 18.2%, 2).  
 
4.2.5. Capital and Coast DHB Analysis 
• See Appendix 1 Table 6, Table 11 and Table 18 
• 215 NZHIS hospitalisations, a rate of 80.6 per 100 000 population. 
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• 563 Wellington Hospital injury notifications reported to RPH, a rate of 211.1 per    
100 000 population. 
• 1 884 NPC human exposure calls, a rate of 706.6 per 100 000 population. 
• The majority of RPH notifications (73.7%, 415) and NZHIS hospitalisations (53.5%, 
115) were intentional. 
• The 15-24 years age group had the highest RPH age-specific rate (502.8 per 100 000 
cases, 213) and NZHIS hospitalisation rate (141.6 per 100 000 population, 60). 
• The majority of RPH notifications (68.9%, 388) and NZHIS hospitalisations (63.7%, 
137) were for females. 
• Where ethnicity was known, the majority of RPH notifications (75.8%, 410/541) and 
NZHIS hospitalisations (69.4%, 145/209) were for Europeans.  Maori had the highest 
ethnicity-specific RPH notification rate (256.6 per 100 000 population, 68) and 
NZHIS hospitalisation rate (117.0 per 100 000 population, 31). 
• Where substance was known (693), the most common RPH substance was 
paracetamol (16.6%, 115) followed by zopiclone (8.5%, 59) and ethanol (5.2%, 36). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (22.8%, 49), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(17.2%, 37).  Of the X61 poisonings where substance was known (8 poisonings and 9 
substances, note one poisoning had two substances listed), the most common 
substance was iminostilbenes (22.2%, 2/9), the other substances each occurred once. 
 
4.2.6. West Coast DHB Analysis 
• See Appendix 1 Table 6, Table 12 and Table 19.  
• 46 NZHIS hospitalisations, a rate of 146.8 per 100 000 population. 
• 5 Grey Hospital injury notifications reported to WCPHU, a rate of 16.0 per 100 000 
population. 
• 159 NPC human exposure calls a rate of 507.4 per 100 000 population. 
• There were 3 unintentional WCPHU notifications and 2 intentional.  Intentional 
exposures were highest for NZHIS hospitalisations (56.5%, 26). 
• The 25-44 years age group had the highest WCPHU age-specific notification rate 
(35.8 per 100 000 population, 3) and the 15-24 years age group had the highest 
NZHIS hospitalisation rate (295.3 per 100 000 population, 10). 
• The majority of WCPHU notifications were for females (80.0%, 4).  There was 
approximately the same number of female and male NZHIS hospitalisations (24 
versus 22). 
• All of the WCPHU notifications where ethnicity was known (2) were for Europeans.  
The majority of NZHIS hospitalisations were also for Europeans (88.9%, 40/45).   
• Where substance was known (6), the most common WCPHU substance was codeine 
phosphate (50.0%, 3), followed by benzylpiperazine, ethanol and zopiclone (for each: 
16.7%, 1). 
• The most common NZHIS external cause code was X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (28.3%, 13), followed by X60 (Intentional self-
poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics) 
(13.0%, 6).  Of the X61 poisonings where substance was known (12 poisonings and 
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15 substances, note some poisonings had more than one substance listed), the most 
common substance was zopiclone (33.3%, 5/15), followed by clonazepam (13.3%, 2). 
 
4.2.7. Southland DHB Analysis 
• See Appendix 1 Table 6, Table 13 and Table 20. 
• 220 NZHIS hospitalisations, a rate of 205.9 per 100 000 population. 
• 163 Invercargill Hospital injury notifications reported to SOPHU, a rate of 152.6 per 
100 000 population. 
• 747 NPC human exposure calls, a rate of 699.3 per 100 000 population. 
• 74.2% (121) of SOPHU injury notifications were deemed intentional.  The majority of 
NZHIS hospitalisations were of unknown intent (41.8%, 92). 
• Highest age-specific injury rate was amongst the 15-24 years age group for SOPHU 
notifications (400.4 per 100 000 population, 55 cases) and amongst the 0-4 years age 
group for NZHIS hospitalisations (463.0 per 100 000 population, 32). 
• The majority of SOPHU notifications (65.6%, 107) and NZHIS hospitalisations 
(54.1%, 119) were for females. 
• Ethnicity data were not collected for SOPHU notifications.  Where ethnicity was 
known the majority of NZHIS hospitalisations were for Europeans (75.6%, 164/217).  
Maori had the highest ethnicity-specific rate (388.8 per 100 000 population, 44). 
• Where substance was known (268), the most common SOPHU substance was 
Paracetamol (12.3%, 33), followed by ethanol (10.1%, 27) and codeine phosphate 
(6.7%, 18). 
• The most common NZHIS external cause code was Y11 (Undetermined poisoning by 
Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (20.0%, 44/220), followed by X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic 
drugs, not elsewhere classified) (10.9%, 24).  Of the Y11 poisonings where substance 
was known (34), the most common substance was zopiclone (23.5%, 8), followed by 
amitriptyline, carbamazepine and citalopram (each: 11.8%, 4). 
 
4.2.8. Specific Analyses 
4.2.8.1.Injuries in Children aged less than five years 
• See Appendix 1 Table 7, Table 21 and Table 22. 
• 801 NZHIS hospitalisations, a rate of 291.2 per 100 000 population (9.3% of total 
NZHIS poisoning hospitalisations). 
• 142 emergency department injury notifications, a rate of 237.6 per 100 000 population 
(note, does not include Auckland City Hospital data as children sent to Starship 
Hospital of which data not available and no relevant attendances to Grey Hospital). 
• The majority of NZHIS hospitalisations (95.5%, 765) and emergency department 
notifications (95.1%, 135) were deemed unintentional.  None of the NZHIS 
hospitalisations were deemed intentional and three of the emergency department 
notifications were deemed intentional. 
• The majority of NZHIS hospitalisations (59.6%, 477) and emergency department 
notifications (54.9%, 78) were males.  Males also had a higher NZHIS hospitalisation 
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rate (339.8 per 100 000 population) and emergency department notification rate (255.3 
per 100 000 population). 
• The majority of NZHIS hospitalisations (where ethnicity was known) were for 
Europeans (58.5%, 467/798), followed by Maori (28.4%, 227).  This trend was also 
evident for the emergency department notifications (74.6%, 85/114; 13.2%, 15, 
respectively).  For the NZHIS hospitalisation data, Maori had the highest ethnicity-
specific rate (341.7 per 100 000 population) followed by Europeans (315.8 per        
100 000 population).  For the emergency department data Europeans had the highest 
ethnicity-specific rate (284.7 per 100 000 population) followed by Pacific Peoples 
(185.7 per 100 000 population, 10). 
• Where substance was known (143), the most common substance involved in 
emergency department notifications was paracetamol (28.0%, 40), followed by 
amoxicillin/clavulanate (4.9%, 7) and diclofenac (3.5%, 5). 
 
4.2.8.2.Paracetamol Poisonings 
• See Appendix 1 Table 23 
• 410 emergency department notifications involving paracetamol, a rate of 31.6 per   
100 000 population.   
• Paracetamol was ranked among the most common substances reported by emergency 
departments (ranked first from Wellington Hospital and Invercargill Hospital, and 
second from Auckland City Hospital, North Shore/Waitakere Hospitals, and 
Masterton Hospital). 
• 53.4% (219) of the paracetamol notifications were deemed intentional (35.6% of the 
cases were of unknown intent). 
• Those aged 15-24 years had the highest age-specific paracetamol poisoning rate (93.2 
per 100 000 population, 182), followed by those aged 0-4 years (46.6 per 100 000 
population, 40). 
• Approximately three quarters of emergency department paracetamol poisoning cases 
were female (74.8%, 306/409).  Females also had the highest sex-specific rate (45.9 
per 100 000 population). 
• Where ethnicity was known, (370) approximately three quarters of the paracetamol 
poisonings were for Europeans (75.1%, 278).  Europeans also had the highest 
ethnicity-specific rate (88.2 per 100 000 population) followed by Maori (77.0 per    
100 000 population, 33). 
 
4.2.8.3.Ethanol Poisonings 
• See Appendix 1 Table 24. 
• 322 NZHIS hospitalisations for 2008 (8.0 per 100 000 population) and 1777 
emergency department ethanol notifications (133.7 per 100 000 population) (note, all 
of these are ethanol when classed as food).   
• Ethanol was ranked among the most common substances reported by emergency 
departments (ranked first from North Shore/Waitakere Hospitals, Auckland City 
Hospital, second from Invercargill, second equal for Grey Hospital and third for 
Wellington Hospital).  
• 19.3% (62) of the NZHIS ethanol notifications were aged less than 18 years (the legal 
drinking age in New Zealand).  5.9% (86/1460) of the Auckland City Hospital ethanol 
notifications were aged less than 18 years, a further 59 notifications in this age group 
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were reported from other emergency departments; North Shore/Waitakere (21.9% of 
ethanol notifications, 50), Masterton (20.0% of ethanol notifications, 5), Wellington 
(5.6% of ethanol notifications, 2), Invercargill (7.4% of ethanol notifications, 2) (the 
Grey Hospital notification was not less than 18 years of age).   
• The majority of NZHIS notifications were intentional (38.8%, 125 however 80 of the 
poisonings were of unknown intent) whereas the majority of emergency department 
ethanol notifications were of unknown intent (89.5%, 1591).  
• The numbers of male and female NZHIS hospitalisations was almost the same (166 
versus 156).  Where sex was known (1769), the majority of emergency department 
notifications were male (59.5%, 1053).  For both NZHIS hospitalisations (8.4 per   
100 000 population) and emergency department notifications (162.4 per 100 000 
population) males had the highest sex-specific rate. 
• Where ethnicity was known, approximately two thirds of the ethanol NZHIS 
hospitalisations (66.5%, 212/319) and emergency department notifications were for 
Europeans (69.5%, 1171/1686) followed by Maori (21.9%, 70 and 11.2%, 188 
respectively).  Maori had the highest ethnicity-specific rate for both NZHIS 
hospitalisations (12.4 per 100 000 population, 70) and emergency department 
notifications (174.7 per 100 000 population, 188). 
 
4.2.8.4.Injuries Involving HSNO Substances 
• See Appendix 1 Table 25 and Table 26. 
• 171 emergency department notifications involving approximately 51 substances 
covered by the HSNO Act. 
• 8 EpiSurv hazardous substances injury notifications. 
• The most common HSNO substance reported was carbon monoxide (17.5%, 30/171), 
followed by hydrocarbons (9.4%, 16), unspecified chemicals (7.6%, 13) and 
hypochlorite (7.0%, 12). 
• The majority of notifications (46.2%, 79) were the result of unknown intent followed 
by unintentional exposures (32.2%, 55). 
• The majority of notifications (58.5%, 100) were for males, they also had the highest 
sex-specific rate (15.8 per 100 000 population). 
• The highest age-specific HSNO substance rate was for the 0-4 years age group (26.8 
per 100 000 population, 23), closely followed by the 15-24 years age group (23.6 per 
100 000 population, 46). 
• Where ethnicity was known (147), the majority of HSNO substance notifications were 
for Europeans (60.5%, 89), followed by Maori (14.3%, 21).  Maori had the highest 
ethnicity-specific rate (20.1 per 100 000 population, 21) followed by Pacific Peoples 
(16.7 per 100 000 population, 16).   
 
4.2.9. Coronial Service Office Data for 2006 and 2007 
• See Appendix 1 Table 28 to Table 32. 
• There were 196 chemical injury deaths in 2006 and 110 in 2007, with corresponding 
annual rates of 4.9 and 2.7 per 100 000 population respectively.  CSO data are 
estimated to be 80-90% complete for 2006.  However, for 2007 CSO data could only 
be accessed up to 1 July 2007. 
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• The majority of the chemical injury deaths were intentional (2006: 61.2%, 120; 2007: 
52.7%, 58).  However, 18.9% (37) of the deaths in 2006 and 26.4% (29) of the deaths 
in 2007 were of unknown intent. 
• Canterbury DHB had the greatest number of chemical injury deaths for 2006 (38) and 
2007 (18).  West Coast DHB had the highest mortality rate in 2006 (9.6 per 100 000 
population, 3) and Wanganui DHB had the highest mortality rate in 2007 (6.4 per   
100 000 population, 4). 
• The mortality rate was highest in the 45-64 years age group in 2006 (7.4 per 100 000 
population, 71) and in 2007 (4.6 per 100 000 population, 44).   
• The majority of deaths in 2006 (70.9%, 139) and in 2007 (57.3%, 63) were males. 
• The majority of deaths where ethnicity was known were for Europeans (2006: 85.3%, 
163/191; 2007: 78.3%, 83/106).  Europeans also had the highest ethnicity specific rate 
(2006: 6.1 per 100 000 population; 2007: 3.1 per 100 000 population). 
• For 2006/2007 combined, just under half of the primary substances identified as 
involved in deaths (where substance class could be identified) were classed as 
household/domestic chemicals (45.8%, 132/288) followed by therapeutics (33.0%, 95) 
and chemicals/drugs of abuse (18.8%, 54). 
• For 2006/2007 combined, the most common primary substance identified involved in 
the deaths (where primary substance involved could be identified) was carbon 
monoxide (40.3%, 116/288), followed by hydrocarbons (8.3%, 24) and methadone 
(5.9%, 17). 
• For 2006/2007 combined, the primary substance identified involved in the intentional 
deaths (where primary substance involved could be identified) was carbon monoxide 
(68.5%, 111/162), followed by hydrocarbon (6.8%, 11) and amitriptyline (4.3%, 7). 
• For 2006/2007 combined, the primary substance identified involved in the 
unintentional deaths (where primary substance involved could be identified) was 
morphine or heroin (19.6%, 11/56), followed by methadone (17.9%, 10) and 
hydrocarbons (16.1%, 9). 
• For 2006/2007 combined, a HSNO substance was the primary substance identified in 
148 deaths. 
 
4.3. Detailed National Analysis 
 
The following section presents national chemical injury results for 2008 from the NZHIS, 
DriftNet, EpiSurv, and NPC data sources plus short ACC and media summary sections.  
Relevant Appendix 1 tables are Table 6, Table 7 and Table 14. 
 
4.3.1. NZHIS Hospitalisation Data 
 
Overview 
 
There were 8571 NZHIS poisoning hospitalisations in 2008, a national rate of 212.8 per     
100 000 population.  This is similar to the number and rate for 2007 (8606, 213.6 per 100 000 
population).  Between 2004 and 2007 there was an apparent annual increase in the number 
and rate of hospitalisations and this has remained steady for 2008 (Figure 3).  It should be 
noted that the ICD 10 codes captured for the NZHIS analysis was expanded for 2007 and 
2008, and this may explain this increase.   
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Figure 3:  Number and Rate of Hospital Admissions for New Zealand, 2004-2008 
 
 
Age 
 
The 15-24 years age group had the highest NZHIS age-specific hospitalisation rate (369.2 per 
100 000 population, 2109), followed by the 0-4 years age group (291.2 per 100 000 
population, 801) (Figure 4).  The 15-24 years age group also had the highest age-specific rate 
in 2007 (370.3 per 100 000 population, 2115).  In 2008, the 15-24 years age group also had 
the highest intentional hospitalisation rate (222.2 per 100 000 population, 1269).  This trend 
was also observed for 2007 (228.1 per 100 000 population, 1303).  The 5-14 years age group 
had the lowest age-specific rate in 2008 (64.1 per 100 000 population, 380).  None of the 
NZHIS hospitalisations for the 0-4 years age group were deemed intentional, however, 27.1% 
(103) of the poisonings in the 5-14 years age group were.   
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Figure 4:  NZHIS Poisoning Hospitalisation Rate by Age Group and Intent, 2008 
 
 
Sex 
 
The majority of hospitalisations were for females (57.7%, 4946), they also had a higher sex-
specific rate (239.8 per 100 000 population versus 184.4 per 100 000 population for males).  
This trend was also observed for 2007 (59.6% of hospitalisations female, 5128 at a rate of 
248.7 per 100 000 population). 
 
 
Intent 
 
The majority of NZHIS poisoning hospitalisations were intentional (48.7%, 4177).  During 
2007, 50.3% of NZHIS hospitalisations were intentional.  In 2008, 1690 (19.7%) of the 
NZHIS hospitalisations were of unknown intent.   
 
The majority of female poisonings were intentional (57.5%, 2846), however for males, the 
majority of poisonings were unintentional (40.0%, 1449).  This trend was also observed for 
2007 (59.4%, 3047 of female poisonings were intentional and 40.9%, 1421 of male 
poisonings were unintentional). 
 
 
Ethnicity 
 
Where ethnicity was known (8480), Europeans accounted for the greatest number of NZHIS 
hospitalisations (71.3%, 6042).  The highest ethnicity-specific rate was for Maori (256.0 per 
100 000 population, 1447).  This trend was also observed during 2007 (71.7%, 6086/8487 of 
hospitalisations were Europeans and the highest rate was for Maori; 245.2 per 100 000 
population, 1386). 
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Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (24.5%, 2102), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (12.9%, 1107).  This trend 
was also observed for 2007 (X61: 25.0%, 2153; and X60: 13.2%, 1138).  Of the 2102 X61 
poisonings in 2008, the most common diagnosis codes were T426 (Other antiepileptic and 
sedative-hypnotic drugs) (20.8%, 438), T424 (Benzodiazepines) (19.9%, 418), and T432 
(Other and unspecified antidepressants) (19.6%, 412).  Of the X61 poisonings where 
substance was known (1200 poisonings and 1489 substances, some poisonings had more than 
one substance listed), the majority were zopiclone (21.0%, 313/1489), followed by quetiapine 
(12.5%, 186) and citalopram (7.7%, 114).  During 2007 zopiclone was also the most common 
substance: 21.2%, 144 however this was followed by citalopram (9.4%, 64) and clonazepam 
(8.1%, 55). 
 
 
DHB  rates 
 
Figure 5 shows the number of NZHIS chemical injury hospitalisations and the corresponding 
rate by DHBs for 2008.  Analysis of the 2008 NZHIS data by DHB showed that the 
Wairarapa DHB had the highest rate of poisoning hospitalisations (310.4 per 100 000 
population, 120) followed by Lakes (275.5 per 100 000 population, 271) and Wanganui 
DHBs (273.4 per 100 000 population, 170).  The lowest hospitalisation rate was recorded in 
Capital and Coast DHB (80.6 per 100 000 population, 215).  During 2007 Capital and Coast 
DHB also had the lowest hospitalisation rate: 103.1 per 100 000 population, 275 however the 
DHB with the highest rate was West Coast: 277.6 per 100 000 population, 87.  In 2008, when 
broken down by intent, Wairarapa DHB had the highest hospitalisation rate resulting from 
intentional poisoning (170.7 per 100 000 population, 66). 
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Figure 5:  Number of NZHIS Chemical Injury Hospitalisations and Rates by DHB, 2008 
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4.3.2.Spraydrift 
 
Seven spraydrift incidents were reported by PHUs during 2008.  This is the similar to the 
number reported during 2007 (8) and continues the low number of spraydrift notifications in 
recent years (Table 2).  For the years 1998-2008, the average number of spraydrift complaints 
reported per year is 12. 
 
Table 2:  Number of Spraydrift Complaints Reported by Year 
Year 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Number of 
complaints 
14 16 13 28 9 4 10 5 7 8 7 
 
 
The majority of spraydrift complaints for 2008 were reported from North Island PHUs (Table 
3).  The specific agrichemical associated with the spraydrift event was known/suspected for 
four of the complaints.  The majority of complaints involved symptoms resulting from 
spraydrift exposure, however, most of the complainants did not seek (or it was unknown 
whether they sought) medical attention.   
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4.3.3.Poison/Chemical Notifiable Disease Analysis 
 
The following section details the 2008 notifications from EpiSurv for the following 
diseases/injuries: chemical poisoning from the environment, decompression sickness, lead 
absorption, toxic shellfish poisoning and hazardous substance injury. 
 
 
Chemical poisoning from the environment 
 
In 2008, 1 case was notified as chemical poisoning from the environment.  This is 
significantly lower than the number notified in 2007 (13 cases).  A Maori female aged 1-4 
years from Northland DHB suffered from a skin rash and seizures and was hospitalised.  It is 
thought that the house she lived in may have previously been a clandestine methamphetamine 
laboratory. 
 
 
Decompression sickness 
 
There were no cases of decompression sickness notified in 2008.  Over the last five years, 
numbers of decompression sickness notifications have been low: none in 2007, 1 in 2006, 1 in 
2005, none in 2004 and 2 in 2003. 
 
As with previous years, the annual number of hospitalisations for decompression sickness 
exceeds the annual number of notifications, indicating a continued under-reporting.  
Diagnosis of decompression sickness as the primary reason for admission (ICD-10-AM code 
T70.3) was specified in 12 cases for 2008.  Since 2002, the number of hospitalisations where 
decompression sickness was recorded as the primary reason for admission ranges from eight 
in 2005 and 2006 to 45 in 2002. 
 
 
Lead absorption 
 
There were 315 cases of lead absorption notified in 2008 (7.4 per 100 000 population), which 
is significantly higher than the number notified in 2007 (1.8 per 100 000 population, 78 
cases).  This is partly due to the lowering of the blood lead level notification in 2007 and the 
introduction of electronic laboratory notification in 2008. 
   
Of the 315 cases notified in 2008, 13 (4.1%) were aged less than 15 years; 2 were aged less 
than 1 year, 5 cases were aged 1-4 years, 4 cases were aged 5-9 years and 2 cases were aged 
10-14 years.  The highest number of notifications in children was recorded in 1999 (25 cases) 
and the lowest in 2004, 2005 and 2007 (6 cases each). 
 
Sex was recorded for 98.1% (309/315) of the cases.  The majority of lead absorption 
notifications were for males (89.3%, 276 cases), compared to females (10.7%, 33 cases). 
 
Ethnicity was recorded for 56.5% (178/315) of the cases.  Of these responses, the majority of 
lead absorption notifications were reported for Europeans (82.6%, 147 cases), followed by 
Maori (7.9%, 14 cases), Pacific Peoples (6.7%, 12 cases) and Other ethnicity (2.8%, 5 cases). 
Of the 141 cases for which hospitalisation status was recorded, two (1.4%) were hospitalised. 
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Table 4 and Table 5 summarise risk factor information for lead absorption cases notified in 
2008.  Several cases had more than one risk factor recorded.  Similar to previous years, the 
most common risk factor for lead absorption for children was living in, or regularly visiting, a 
building built prior to 1970 that had paint chalking/flaking, and/or had recently undergone 
alteration or refurbishment.  Unlike previous years, for adults the most common risk factor for 
lead absorption was exposure to a high-risk occupation. 
 
Blood lead levels were recorded for all of the notifications.  For child notifications, blood lead 
level concentrations ranged from 0.48 to 1.9 µmol/L with a median of 0.7 µmol/L.  For adult 
notifications, blood lead level concentrations ranged from 0.36 to 6.1 µmol/L with a median 
of 0.71 µmol/L. 
 
Two lead poisoning clusters were reported by Auckland Regional Public Health Service 
during 2008.  One cluster involved four family members who were exposed to lead paint 
when it was removed from their house.  The remaining cluster involved 100 persons who 
were occupationally exposed to lead during the removal of paint from the Auckland Harbour 
Bridge.  Cases continue to be reported from this cluster. 
 
 
Table 4:  Exposure to risk factors associated with lead absorption for adults (cases aged 15 years and 
over), 2008 
Risk factor Yes No Unknown %a 
Case had exposure to high-risk occupationb 213 58 31 78.6 
Cased lived in or regularly visited a building built prior to 1970c 67 51 184 56.8 
Case had exposure through hobbiesd 59 65 178 47.6 
Close contact of case was occupationally exposed to lead 4 107 191 3.6 
a "%" refers to the percentage of cases that answered "yes" out of the total number of cases for which this information was 
supplied.  Several cases had more than one risk factor 
b Occupations included painter (37), radiator repairer (12), builder/labourer (8), cleaner (5), lead lighter (5), plastics worker 
(4), metallurgist (3), welder (3), foundry worker (2), laboratory technician (3), supervisor (2), electrician (2), aeronautical 
engineer (1), aircraft refueller (1), boilermaker (1), engineer (1), factory process worker (1), fitter (1), meat process worker 
(1), sand stripper (1), yardsman (1) and unspecified (118) 
c Of these, 32 cases lived in or regularly visited a building that had chalking/flaking paint, and/or had recently undergone 
alterations or refurbishment 
d Hobbies were reported as shooting (34), home renovations (6), making sinkers (4), making lead bullets (3), lead lighting 
(3), boat building (2), car restorer (2), painter (2), antique furniture restorer (1), circuit board repairer (1), figurine maker 
(1) and unspecified (1) 
 
 
Table 5:  Exposure to risk factors associated with lead absorption for children (cases aged less than 15 
years), 2008 
Risk factor Yes No Unknown %a 
Cased lived in or regularly visited a building built prior to 1970 that had paint 
chalking/flaking, and/or had recently undergone alterations or refurbishment 
6 1 6 85.7 
Pica behaviour 4 6 3 40.0 
Case played in soil containing paint debris 1 6 6 14.3 
Close contact of case was occupationally exposed to lead 1 8 4 11.1 
Case lived near an industry that is likely to release lead 0 10 3 0.0 
a "%" refers to the percentage of cases that answered "yes" out of the total number of cases for which this information was 
supplied.  Several cases had more than one risk factor. 
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Toxic shellfish poisoning 
 
There was 1 suspected case of toxic shellfish poisoning reported in 2008.  This continues the 
trend of low numbers of toxic shellfish poisoning cases reported in past years.  Since 1997, 
numbers of cases reported ranged from 1 in 1998, 2002, 2006 and 2008 to 7 cases in 1999.   
 
The 2008 notification was a 51 year old male from Nelson Marlborough DHB who collected 
and consumed mussels from Wainui Bay in the Tasman District.  The type of toxic shellfish 
poisoning was unspecified.  The case did not require hospitalisation.   
 
 
Hazardous substance injury 
 
8 cases of hazardous substance injury (HSI) were notified during 2008, this compares to 3 
during 2007.  It is important to note that the case report form went live in EpiSurv on 
19 September 2007 therefore data from all of 2007 will not be captured.  
 
The first notification occurred in June when a man from Waikato DHB was exposed to 
unsealed asbestos in a ceiling while renovating an old house.  He had been exposed to 
asbestos during 2007 and 2008 and was referred to a respiratory physician.  In October a three 
case cluster of HSI was reported from Waikato DHB.  The men were on a camping trip and 
were accidentally exposed to carbon monoxide fumes from a gas cooker inside a cabin.  Two 
of the men died and the survivor was hospitalised.  This cluster was heavily publicised in the 
media.  Four HSI cases were reported from Auckland Regional Public Health Service in 
November.  A three year old female was accidentally exposed to solvents (Coopers Flush It 
and Coopers Strip It) and received corrosive burns.  She was hospitalised in Starship 
Children’s Hospital.  A female from Waitemata DHB was accidentally exposed to carbon 
monoxide in her caravan from a gas cooking supply.  The patient had several recent 
admissions to hospital for unexplained collapse and loss of consciousness episodes.  The last 
two notifications involved male workers at a public swimming pool who were mixing 
chemicals and were exposed to chlorine vapours, both were hospitalised. 
 
4.3.4.  National Poisons Centre call data 
 
During 2008, the NPC received 35 138 phone calls (includes exposure calls, information calls 
and product enquires), of these, 23 233 related to actual exposures (including chronic 
exposures, acute human exposures and animal exposures).  Acute human exposure calls 
accounted for 64.8% (22 755) of the total number of calls received.  During 2007, the NPC 
received 32 985 phone calls (includes exposure calls, information calls and product enquires), 
of these, 22 276 related to actual exposures (including chronic exposures, acute human 
exposures and animal exposures). Acute human exposure calls accounted for 66.1% (21 805) 
of the total number of calls received. 
 
 
Age 
 
Where age was known (22 181), the majority of exposure phone calls were for those aged     
5-14 years (53.0%, 11 767), followed by the 0-4 years age group (21.6%, 4794).  These two 
age groups also had the highest age-specific rates (1986.0 per 100 000 population and 1742.8 
per 100 000 population, respectively).  During 2007 where age was known (16 988), 
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approximately two thirds of exposure phone calls were for those aged 0-4 years (66.4%,       
11 275), followed by the 25-44 years (8.8%, 1499), and 5-14 years age groups (8.6%, 1466). 
The 0-4 years age group also had the highest age-specific rate (4098.9 per 100 000 
population), followed by the 5-14 years (247.4 per 100 000 population, 1466) and 15-24 years 
age groups (226.6 per 100 000 population, 1294).  
 
 
Intent 
 
The NPC uses different definitions than the other CISS data sources for intent; in particular 
‘abuse’ as well as ‘intentional’.  Abuse would be classified as using any substance for any 
reason other that it is intended and also includes taking any amount of illicit substances.  
Intentional poisoning would be knowingly using a legal substance with the intent of harm or 
deliberate effect (Shieffelbien, 2007, 20 September).  The majority of NPC human exposure 
phone calls were for child exploration (54.4%, 12 374), followed by unintentional exposures 
(33.5%, 7627).  Intent was unknown for 1.0% (236) of the calls.  During 2007 the majority of 
NPC human exposure phone calls were for child exploration (54.6%, 11 915), followed by 
unintentional exposures (33.9%, 7400). Intent was unknown for 0.9% (188) of the calls. 
 
 
Sex 
 
Where sex was known (22 356), the number of human exposure calls was similar for females 
(50.2%, 11 224) and males (49.8%, 11 132).  The sex-specific rate was slightly higher for 
males (566.3 per 100 000 population) than females (544.2 per 100 000 population).  The 
number of human exposure calls by intent was generally split evenly by sex with the 
exception of intentional exposures (69.1% female).  During 2007 where sex was known      
(21 272), the number of human exposure calls was similar for females (49.7%, 10 570) and 
males (50.3%, 10 702). The sex-specific rate was slightly higher for males (544.5 per 100 000 
population) than females (512.5 per 100 000 population). The number of human exposure 
calls by intent was generally split evenly by sex with the exception of intentional exposures 
(70.7% female) and abuse exposures (66.2% male).   
 
 
Ethnicity 
 
Where ethnicity was known (12 523), the majority of human exposure calls were for 
Europeans (79.2%, 9921), followed by Maori (10.7%, 1344).  The highest ethnicity-specific 
rate was for Europeans (368.3 per 100 000 population) followed by Maori (237.7 per 100 000 
population).  During 2007 the highest ethnicity-specific rate was also for Europeans (264.0 
per 100 000 population, 7112) followed by Maori (142.0 per 100 000 population, 803). 
 
 
Substance 
 
Where substance class was known (19 895), the majority of human exposure calls were for 
therapeutics (44.3%, 8818), followed by household/domestic chemicals (28.6%, 5698) and 
agrichemicals (9.3%, 1850).  Paracetamol was the most common substance involved in 
human exposure calls to the NPC (5.4%, 1230/22 646) followed by dishwashing liquid (2.8%, 
640) and all purpose cleaner (2.4%, 547).  During 2007 the most common substance involved 
in human exposure calls to the NPC was also paracetamol (5.2%, 1127) followed by 
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dishwashing liquid (2.9%, 628).  During 2008 a HSNO substance was involved in 30.8% of 
the calls (6966/22 646), the most common substances were dishwashing liquid (9.2%, 
640/6966), all purpose cleaner (7.9%, 547) and hydrocarbons (6.9%, 481). 
  
4.3.5. ACC Analysis 
 
During 2008, there were approximately 506 ACC claims relating to chemical injuries, a rate 
of 12.6 per 100 000 population (Table 27) (slightly more than 2007 where there were 
approximately 489 claims related to chemical injuries, a rate of 12.1 per 100 000 population).  
There were more male (53.2%, 269) than female (46.8%, 237) ACC claims.  Males also had a 
higher sex-specific rate (13.7 per 100 000 population versus 11.5 per 100 000 population for 
females).  Where ethnicity was known (482), the majority of claims were for Europeans 
(68.5%, 330), followed by Maori (18.0%, 87).  The highest ethnicity-specific rate was for 
Maori (15.4 per 100 000 population) followed by Europeans (12.3 per 100 000 population).    
 
Approximately half of the claims (49.6%, 251) related to ‘toxic effects of substances chiefly 
non-medicinal as to source’ (ICD-10 diagnosis codes T51.0 – T65.9), followed by ‘poisoning 
by drugs, medicaments and biological substances’ (ICD-10 diagnosis codes T36.0 – T50.9) 
(39.1%, 198).  Of particular interest is that although no decompression sickness notifications 
were reported in EpiSurv for 2008, 7 claims were received.     
 
4.3.6. Media Analysis 
 
During 2008, national and local media articles of interest were identified by the utilisation of 
ESR library search services.  These illustrate the degree of underreporting of chemical 
poisoning from the environment and hazardous substances injury cases to EpiSurv.  Media 
articles ranged from a woman who suffered serious burns after trying to set a gas bottle on 
fire in a party trick (Keith, 2008) to a worker who fell into a vat of chemicals (Francis, 2008).  
In these instances human health effects were documented or the persons involved visited a 
healthcare institution.  A selection of the injuries caused by hazardous substances are 
documented below, only one of these was reported via EpiSurv (carbon monoxide incident in 
Raglan). 
 
During 2008 a number of newspapers reported various workplace incidents that resulted in 
harm, often involving inhalation of hazardous substances.  On 14 April, ten workers were 
transported to hospital after inhaling chlorine fumes at a chicken processing factory in 
Rolleston (Nordqvist, 2008).  On 3 September, 40 workers at a Christchurch manufacturing 
plant needed medical care after a chemical spill, 9 of which required hospitalisation.  
Symptoms included watering eyes, sore throats and coughing fits (No author, 2008a; Radio 
New Zealand, 2008). 
 
There were a number of high profile events that were reported in the media during 2008.  On 
5 April one fireman died and several were seriously injured when they attended a fire at 
Icepak’s Tamahere coolstore (No author, 2008b; Taylor, 2008).  The plant erupted into a 
fireball as the result of a large amount of highly flammable propane LPG being present.  On 
the 8 September, two men died and one was seriously injured and later hospitalised after they 
suffered carbon monoxide poisoning at a motor camp near Raglan (Broun, 2008; Feek, 2008; 
Feek & Broun, 2008; McDonald & Feek, 2008).  They inhaled the fumes from a charcoal 
Chemical Injury Surveillance for New Zealand, 2008 34 June 2009 
  
barbecue they brought inside to heat their small cabin, the two men were found dead in their 
beds and the survivor lying on the floor against the door.   
 
The incidents above are a summary of the many chemical and hazardous substance injuries 
which are reported in the media that are generally not notified to the local PHUs for reporting 
via EpiSurv. 
 
4.4. Detailed Waitemata DHB Analysis 
 
Overview 
 
There were 1159 NZHIS poisoning hospitalisations reported for Waitemata DHB during 
2008, a rate of 240.7 per 100 000 population.  Waitemata DHB is ranked 6/21 when DHBs 
are ordered from highest to lowest rate. 
 
A total of 672 North Shore/Waitakere Hospital emergency department attendance 
notifications were reported for 2008, a rate of 139.5 per 100 000 population. 
 
   
Age 
 
The 15-24 years age group had the highest NZHIS hospitalisation rate (443.1 per 100 000 
population, 300) and emergency department rate (353.0 per 100 000 population, 239), 
followed by the 0-4 years age group (322.3 per 100 000 population, 106; 200.7 per 100 000 
population, 66, respectively). 
 
 
Intent 
 
The majority of NZHIS hospitalisations (51.1%, 592) and emergency department notifications 
(44.3%, 298) were for intentional poisoning, this also had the highest rate (122.9 per 100 000 
population; 61.9 per 100 000 population, respectively). 
 
 
Sex 
 
The majority of NZHIS hospitalisations (56.9%, 660) and emergency department notifications 
(58.4%, 392/671) were for females.  For both the NZHIS hospitalisations (267.0 per 100 000 
population) and emergency department notifications (158.6 per 100 000 population), females 
had the highest sex-specific rate. 
 
 
Ethnicity 
 
Where ethnicity was known, the majority of NZHIS hospitalisations (74.4%, 855/1149) and 
emergency department notifications (78.4%, 515/657) were for Europeans.  The highest 
ethnicity-specific rate was for Maori for NZHIS hospitalisations (314.9 per 100 000 
population, 135) and Europeans for the emergency department notifications (163.4 per       
100 000). 
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Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (26.8%, 311), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (13.2%, 153).  Of the 311 
X61 poisonings, the most common diagnosis code was T424 (Benzodiazepines) (23.5%, 73), 
followed by T426 (Other antiepileptic and sedative-hypnotic drugs) (22.8%, 71).  Of the X61 
poisonings where substance was known (157 poisonings and 218 substances, some poisonings 
had more than one substance), the most common substance was zopiclone (22.5%, 49/218), 
followed by quetiapine (12.4%, 27) and citalopram (8.3%, 18).   
 
Where substance class was known (590), the most common substance class for the emergency 
department notifications was chemicals/drugs of abuse (46.9%, 277), followed by 
therapeutics (44.2%, 261).  Where substance was known (564), the most common emergency 
department notification substance was ethanol (40.6%, 229), followed by paracetamol 
(18.1%, 102) and zopiclone (5.1%, 29). 
 
 
4.5.   Detailed Auckland DHB Analysis 
 
Overview 
 
There were 921 NZHIS poisoning hospitalisations reported for Auckland DHB during 2008, a 
rate of 227.6 per 100 000 population (compared with 231.3 per 100 000 population, 936 for 
2007).  Auckland DHB is ranked 8/21 when DHBs are ordered from highest to lowest rate.  
Figure 6 shows that following a stable number of admissions for 2004 and 2005 there was an 
increase during 2006 which has remained stable over the subsequent years.  It should be noted 
that the ICD 10 codes captured for the NZHIS analysis was expanded for 2007 and 2008.   
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Figure 6:  Number and Rate of Admissions for Auckland District Health Board, 2004-2008 
 
A total of 2017 Auckland City Hospital emergency department attendance notifications were 
reported for 2008, a rate of 498.5 per 100 000 population.  Figure 7 shows that there has been 
a general annual increase in the number of emergency department notifications between 2004 
and 2007, with the 2008 number and rate being less than 2007 (648.5 per 100 000 population, 
2624) but greater than 2006. 
 
These data are incomplete for children as the majority of these cases are seen at Starship 
Children’s Hospital and notification data from this hospital are not routinely received by 
ARPHS.   
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Figure 7:  Number and Rate of Emergency Department Attendances to Auckland City Hospital, 2004-
2008 
 
 
Age 
 
The 15-24 years age group had the highest age-specific NZHIS hospitalisation rate (358.4 per 
100 000 population, 241), followed by the 0-4 years age group (287.9 per 100 000 population, 
75).  This trend was also observed during 2007 (15-24 years age group: 340.6 per 100 000 
population, 299; and 0-4 years age group 330.1 per 100 000 population, 86).  In 2008 the 
highest ARPHS age-specific notification rate was for the 15-24 years age group (1180.9 per 
100 000 population, 794) followed by the 25-44 years age group (545.6 per 100 000 
population, 743).  During 2007 the highest ARPHS age-specific notification rate was also for 
the 15-24 years age group (1609.2 per 100 000 population, 1082) followed by the 25-44 years 
age group (738.0 per 100 000 population, 1005). 
 
 
Intent 
 
The majority of NZHIS hospitalisations (54.0%, 497) were for intentional poisoning, it also 
had the highest rate (122.8 per 100 000 population).  This trend was also observed during 
2007 (51.4%, 481 were intentional poisoning, a rate of 118.9 per 100 000 population).  In 
2008 the majority of ARPHS notifications were of unknown intent (93.3%, 1882), this also 
had the highest rate (465.2 per 100 000 population).  During 2007 the majority of ARPHS 
notifications were for intentional poisoning (46.6%, 1222).   
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Sex 
 
The majority of NZHIS hospitalisations were for females (55.9%, 515), they also had a higher 
sex-specific rate (248.3 versus 205.9 per 100 000 population for males).  This trend was also 
observed during 2007 (57.7%, 540 hospitalisations were for females, a rate of 260.4 per     
100 000 population).  In 2008 where sex was known (2004) for ARPHS notifications, the 
majority were for males (55.5%, 1112).  During 2007 where sex was known (2614) for 
ARPHS notifications the majority were for males (55.9%, 1460)).  In 2008 the sex-specific 
rate was higher for males (563.9 versus 430.1 per 100 000 population for females).   
 
 
Ethnicity 
 
Where ethnicity was known, the majority of NZHIS hospitalisations (64.3%, 581/904) and 
ARPHS notifications (68.7%, 1339/1948) were for Europeans.  The highest ethnicity-specific 
rate was for Maori for both the NZHIS hospitalisations (361.9 per 100 000 population, 108) 
and ARPHS notifications (690.3 per 100 000, 206).  This trend was also observed during 
2007 where ethnicity was known, the majority of NZHIS hospitalisations (62.7%, 576/919) 
and ARPHS notifications (66.1%, 1642/2485) were for Europeans. The highest ethnicity-
specific rate was for Maori for both the NZHIS hospitalisations (382.0 per 100 000 
population, 114) and ARPHS notifications (1045.5 per 100 000, 312) during 2007. 
 
 
Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (27.3%, 251), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (15.4%, 142).  This trend 
was also observed during 2007 (most common code was X61: 27.6%, 258 followed by X60: 
13.1%, 123).  Of the 251 X61 poisonings during 2008, the most common diagnosis code was 
T424 (Benzodiazepines) (26.3%, 66), followed by T426 (Other antiepileptic and sedative-
hypnotic drugs) (23.1%, 58).  Of the X61 poisonings where substance was known (218 
poisonings and 279 substances, some poisonings had more than one substance), the most 
common substance was zopiclone (22.9%, 64/279), followed by quetiapine (10.4%, 29) and 
citalopram (8.2%, 23).  The trend for 2007 was the same in regard to zopiclone being the most 
substance (38.4%, 31/109); however, this was followed by clonazepam (11.0%, 12) and 
fluoxetine (9.2%, 10). 
 
Where substance class was known (2754), the most common substance class for ARPHS 
notifications was chemicals/drugs of abuse (61.7%, 1698), followed by therapeutics (35.4%, 
975).  Where substance was known (2756), the most common ARPHS notification substance 
was ethanol (53.0%, 1460), followed by paracetamol (5.3%, 146) and zopiclone (3.9%, 107).  
This trend was also observed during 2007, where substance class was known (2973), the most 
common substance class for ARPHS notifications was chemicals/drugs of abuse (67.0%, 
1993), followed by therapeutics (31.3%, 932). Where substance was known (2963), the most 
common ARPHS notification substance was ethanol (55.1%, 1634), followed by paracetamol 
(4.6%, 137) and zopiclone (3.5%, 103). 
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4.6. Detailed Wairarapa DHB Analysis 
 
Overview 
 
There were 120 NZHIS poisoning hospitalisations reported for Wairarapa DHB during 2008, 
a rate of 310.4 per 100 000 population.  Wairarapa DHB has the highest hospitalisation rate 
compared to the other DHBs.  Figure 8 shows that the numbers and rate of hospitalisations 
was generally stable between 2004 and 2006 and has subsequently increased for 2007 (264.2 
per 100 000 population, 102) and 2008.  It should be noted that the ICD 10 codes captured for 
the NZHIS analysis was expanded for 2007 and 2008. 
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Figure 8:  Number and Rate of Admissions for Wairarapa District Health Board, 2004-2008 
 
A total of 92 Masterton Hospital Emergency Department notifications were reported for 2008, 
a rate of 238.0 per 100 000 population.  Unfortunately data are not available for 2007 and in 
2006 there were 80 attendances. 
 
 
Age 
 
The highest age-specific rate for NZHIS poisoning hospitalisations was for the 15-24 years 
age group (780.1 per 100 000 population, 33), followed by the 0-4 years age group (492.0 per 
100 000 population, 12).  For RPH notifications, the highest age-specific was for the 0-4 years 
age group (574.0 per 100 000 population, 14) followed by the 15-24 years age group (425.5 
per 100 000 population, 18). 
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Intent 
 
The majority of NZHIS hospitalisations (55.0%, 66) and RPH notifications (62.0%, 57) were 
for intentional exposure, this also had the highest rate by intent (170.7 per 100 000 population 
and 147.5 per 100 000 population, respectively).  Unknown intention accounted for 23.3% 
(28) of the hospitalisations and 10.9% (10) of the notifications, respectively. 
 
 
Sex 
 
Females accounted for the majority of NZHIS hospitalisations (55.0%, 66) and RPH 
notifications (60.9%, 56).  Females also had the highest sex-specific notification rate (332.3 
per 100 000 population and 281.9 per 100 000 population, respectively). 
 
 
Ethnicity 
 
Where ethnicity was known, approximately three quarters of the NZHIS hospitalisations 
(75.8%, 91) and RPH notifications (76.7%, 56/73) were for Europeans.  The highest ethnicity-
specific rate both the NZHIS hospitalisations (455.2 per 100 000 population, 25) and RPH 
notifications (273.1 per 100 000, 15) was for Maori. 
 
 
Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (23.3%, 28), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (15.0%, 18).  Of the 28 
X61 poisonings, the most common diagnosis code was T426 (Other antiepileptic and 
sedative-hypnotic drugs) (25.0%, 7), followed by T424 (Benzodiazepines) (21.4%, 6) and 
T432 (Other and unspecified antidepressants) (21.4%, 6).  Of the 28 X61 poisonings, the 
substance was known for 10 poisonings with 11 substances involved (one poisoning had two 
substances listed), zopiclone was the most common substance (27.3%, 3/11), followed by 
citalopram and methotrimeprazine (for each: 18.2%, 2) 
 
Where substance class was known (122) the most common substance class for RPH 
notifications was therapeutics (60.7%, 74) followed by chemicals/drugs of abuse (23.8%, 29).  
Where substance was known (125), the most common RPH substance notification was 
ethanol (20.0%, 25), followed by paracetamol (11.2%, 14), and zopiclone (8.0%, 10). 
 
 
4.7.  Detailed Capital and Coast DHB Analysis 
 
Overview 
 
There were 215 NZHIS hospitalisations recorded for Capital and Coast DHB, a rate of 80.6 
per 100 000 population.  This is the lowest NZHIS hospitalisation rate by DHB for 2008, 
similar for recent years (103.1 per 100 000 population, 275 for 2007).  Figure 9 shows the 
trend in hospital admissions for Capital and Coast DHB between 2004 and 2008.  It can be 
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seen that admissions and the rate were stable between 2004 and 2005 and subsequently 
increased in 2006.  The 2007 numbers and rate were at a similar level to 2006 and then 
dropped in 2008 to levels similar in 2004 and 2005.  It should be noted that the ICD 10 codes 
captured for the NZHIS analysis was expanded for 2007 and 2008. 
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Figure 9:  Number and Rate of Admissions for Capital and Coast District Health Board, 2004-2008 
A total of 563 Wellington City Emergency Department notifications were reported to RPH for 
2008, a rate of 211.1 per 100 000 population.  The number and rate is slightly lower than 
reported for 2007 (216.0 per 100 000 population, 576) (Figure 10, note data not available for 
2004). 
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Figure 10:  Number and Rate of Wellington Hospital Emergency Department Attendances, 2005-2008 
 
 
Age 
 
The highest age-specific NZHIS hospitalisation rate was for the 15-24 years age group (141.6 
per 100 000 population, 60), followed by the 0-4 years age group (137.0 per 100 000 
population, 24).  In 2007 the highest age-specific rate was also for the 15-24 years age group 
(172.3 per 100 000 population, 73), however, this was followed by the 25-44 years age group 
(125.4 per 100 000 population, 107).  In 2008 the highest age-specific RPH notification rate 
was for the also for the 15-24 years age group (502.8 per 100 000 population, 213) followed 
by the 0-4 years age group (222.7 per 100 000 population, 39).  This trend was also observed 
during 2007 (15-24 years age group: 481.5 per 100 000 population, 201; followed by the 0-4 
years age group: 256.9 per 100 000 population, 45) 
 
 
Intent 
 
The majority of NZHIS hospitalisations (53.5%, 115) and RPH notifications (73.7%, 415) 
were for intentional exposure.  Intentional exposure also had the highest rate for both the 
NZHIS hospitalisations (43.1 per 100 000 population) and RPH notifications (155.6 per     
100 000 population).  This trend was also observed for 2007, the majority of NZHIS 
hospitalisations (62.9%, 173) and RPH notifications were for intentional exposure (70.8%, 
408).  Intentional exposure also had the highest rate for both the NZHIS hospitalisations (64.9 
per 100 000 population) and RPH notifications (153.0 per 100 000 population).   
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Sex 
 
Females accounted for the majority of NZHIS hospitalisations (63.7%, 137) and RPH 
notifications (68.9%, 388).  The sex-specific rate was highest for females for both the NZHIS 
hospitalisations (99.2 per 100 000 population) and RPH notifications (280.9 per 100 000 
population).  This trend was also observed during 2007, females accounted for the majority of 
NZHIS hospitalisations (64.4%, 177) and RPH notifications (67.7%, 390). The sex-specific 
rate was highest for females for both the NZHIS hospitalisations (128.1 per 100 000 
population) and RPH notifications (282.3 per 100 000). 
 
 
Ethnicity 
 
Where ethnicity was known, approximately 70% of the NZHIS hospitalisations (69.4%, 
145/209) and RPH notifications (75.8%, 410/541) were for Europeans.  The highest ethnicity-
specific rate was for Maori for both the NZHIS hospitalisations (117.0 per 100 000 
population, 31) and RPH notifications (256.6 per 100 000, 68).  This trend was also observed 
during 2007, where ethnicity was known, approximately three-quarters of the NZHIS 
hospitalisations (71.8%, 191/266) and RPH notifications (75.4%, 422/560) were for 
Europeans. The highest ethnic-specific rate was for Maori for both the NZHIS 
hospitalisations (124.5 per 100 000 population, 33) and RPH notifications (234.0 per 100 000, 
62). 
 
 
Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (22.8%, 49), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (17.2%, 37).  This trend 
was also observed for 2007 (X61: 30.5%, 84 followed by X60: 19.6%, 54).  Of the 49 X61 
poisonings in 2008, the most common diagnosis code was T432 (Other and unspecified 
antidepressants) (18.4%, 9), followed by T426 (Other antiepileptic and sedative-hypnotic 
drugs) (16.3%, 8) and T430 (Tricyclic and tetracyclic antidepressants) (16.3%, 8).  Of the 49 
X61 poisonings, the substance was known for 8 poisonings with 9 substances involved (one 
poisoning had two substances listed) the only substance that occurred more than once was 
iminostilbenes (2).  During 2007 the substance was known in only one hospitalisation, the 
substance was zopiclone. 
 
Where substance class was known (648) the most common substance class for RPH 
notifications was therapeutics (86.4%, 560) followed by chemicals/drugs of abuse (12.8%, 
83).  Where substance was known (693), the most common RPH substance notification was 
paracetamol (16.6%, 115), followed by zopiclone (8.5%, 59) and ethanol (5.2%, 36).  The 
trends observed for 2007 were similar, where substance class was known (693) the most 
common substance class for RPH notifications was therapeutics (85.1%, 590) followed by 
chemicals/drugs of abuse (9.2%, 64). Where substance was known (689), the most common 
RPH substance notification was paracetamol (18.4%, 127), followed by zopiclone (7.8%, 54), 
clonazepam (4.8%, 33), quetiapine (4.4%, 30) and ibuprofen (4.2%, 29). 
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4.8.  Detailed West Coast DHB Analysis 
 
Overview 
 
There were 46 NZHIS hospitalisations recorded for West Coast DHB in 2008, a rate of 146.8 
per 100 000 population.  West Coast DHB is ranked 18/21 when hospitalisation rates are 
ranked from highest to lowest.  The rate and number is considerably lower than 2007 (277.6 
per 100 000, 87) and the lowest during the last five years Figure 11.  It should be noted that 
the ICD 10 codes captured for the NZHIS analysis was expanded for 2007 and 2008. 
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Figure 11:  Number and Rate of Admissions for West Coast District Health Board, 2004-2008 
 
There were 5 emergency department notifications (16.0 per 100 000 population) from Grey 
Hospital relating to chemical injury during 2008.  This is the lowest number reported during 
the previous recent years (Figure 12).  It should be noted that there were a number of months 
where notifications were not passed on from Grey Hospital to WCPHU. 
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Figure 12:  Number and Rate of Emergency Department Attendances for Grey Hospital, 2004-2008 
 
 
Intent 
 
For the NZHIS hospitalisations, intentional (56.5%, 26) exposures were the most common 
intent.  The majority of emergency department attendance injuries were unintentional (60.0%, 
3).  The trend for NZHIS hospitalisations in 2007 is different with intentional (40.2%, 35) and 
unintentional (40.2%, 35) exposures being equal as the most common intent. The majority of 
WCPHU injuries were intentional (9/15, 60.0%). 
 
 
Sex 
 
The number of female (52.2%, 24) and male (47.8%, 22) NZHIS hospitalisations were 
similar.  The majority of WCPHU injuries however were females (80.0%, 4).  Females had 
the highest NZHIS hospitalisation (155.6 per 100 000 population) and WCPHU (26.0 per 
100 000 population) sex-specific rate.  The trend observed for 2007 is similar, there were 
approximately equal numbers of female (51.7%, 45) and male (48.3%, 42) NZHIS 
hospitalisations. The majority of WCPHU injuries however were females (80.0%, 12). 
Females had the highest NZHIS hospitalisation (291.8 per 100 000 population) and WCPHU 
(78.1 per 100 000 population) sex-specific rate. 
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Age 
 
The highest age-specific rate for NZHIS hospitalisations was for the 15-24 years age group 
(295.3 per 100 000 population, 10), followed by the 25-44 years age group (179.2 per 100 000 
population, 15).  The highest age-specific WCPHU notification rate was for the 25-44 years 
age group (35.8 per 100 000 population, 3).  The trend observed for 2007 is different with the 
highest age-specific rate for NZHIS hospitalisations being the 15-24 years age group (738.3 
per 100 000 population, 25), followed by the 0-4 years age group (316.5 per 100 000 
population, 6). The highest age-specific WCPHU notification rate was for the 15-24 years age 
group (177.2 per 100 000 population, 6). 
 
 
Substance 
 
The most common NZHIS external cause code was X61 (Intentional self-poisoning by and 
exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not 
elsewhere classified) (28.3%, 13), followed by X60 (Intentional self-poisoning by and 
exposure to nonopioid analgesics, antipyretics and antirheumatics) (13.0%, 6).  This is similar 
to the trend observed during 2007 (X61: 17.2%, 15 and X60: 13.8%, 12).  Of the 13 X61 
poisonings during 2008, the most common diagnosis codes were T424 (Benzodiazepines) 
(30.8%, 4), followed by T432 (Other and unspecified antidepressants) (23.1%, 3).  Of the X61 
poisonings, the substance was known for 12 poisonings with 15 substances involved (some 
poisonings had more than one substance listed) the most common substance was zopiclone 
(33.3%, 5/15), followed by clonazepam (13.3%, 2).  For 2007 where substance was known 
(15), the most common substance was clonazepam (20.0%, 3), followed by buspirone, 
fluoxetine, sodium valproate and zopiclone (for each: 13.3%, 2). 
 
Therapeutic substances were associated with the majority of the WCPHU notifications 
(62.5%, 5/8).  Codeine phosphate was the most common substance involved in the injuries 
(50.0%, 3/6). During 2007 therapeutic substances were associated with the majority of the 
WCPHU notifications (27/32, 84.4%), and codeine phosphate, ethanol, paracetamol and 
sodium valproate were the most common substances involved in the injuries (for each: 9.4%, 
3/32). 
 
4.9.  Detailed Southland DHB Analysis 
 
 
Overview 
 
There were 220 NZHIS poisoning hospitalisations recorded for Southland DHB for 2008, a 
rate of 205.9 per 100 000 population.  Southland DHB is ranked 13/21 when DHBs are 
ranked from highest to lowest hospitalisation rate.  The 2008 rate and number of 
hospitalisations is lower than 2007 (238.7 per 100 000 population, 255) but above previous 
years (Figure 13).  It should be noted that the ICD 10 codes captured for the NZHIS analysis 
was expanded for 2007 and 2008.   
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Figure 13:  Number and Rate of Admissions for Southland District Health Board, 2004-2008 
 
163 injury notifications (152.6 per 100 000 population) from Invercargill Hospital were 
reported.  This is greater than the rate and number of notifications for recent years (during 
2007 118 injury notifications reported at a rate of 110.5 per 100 000 population) but is not as 
high as reported during 2004 and 2005 (Figure 14). 
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Figure 14:  Number and Rate of Emergency Department Attendances for Invercargill Hospital, 2004-2008 
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Age 
 
The highest age-specific NZHIS hospitalisation rate (463.0 per 100 000 population, 32) 
occurred in the 0-4 years age group.  This was closely followed by the 15-24 years age group 
(451.3 per 100 000 population, 62).  For the SOPHU notifications, the 15-24 years age group 
had the highest age-specific injury rate (400.4 per 100 000 population, 55) followed by the   
0-4 years age group (332.8 per 100 000 population, 23).  These trends were also observed 
during 2007, the highest age-specific NZHIS hospitalisation rate (680.0 per 100 000 
population, 47) occurred in the 0-4 years age group.  This was followed by the 15-24 years 
age group (429.5 per 100 000 population, 59).  For the SOPHU notifications, the 15-24 years 
age group had the highest age-specific injury rate (269.3 per 100 000 population, 37) followed 
by the 0-4 years age group (245.9 per 100 000 population, 17). 
 
 
Sex 
 
The number of female injury notifications greatly outnumbered the number of male injury 
notifications for SOPHU notifications (107 and 56 respectively).  For the NZHIS 
hospitalisations, females slightly outnumbered males (119 versus 101 respectively).  During 
2007 the number of female injury notifications greatly outnumbered the number of male injury 
notifications for both the NZHIS hospitalisations (153 and 102, respectively) and SOPHU 
notifications (72 and 46 respectively). 
 
 
Intent 
The majority of NZHIS hospitalisations were of unknown intent (41.8%, 92).  Three-quarters 
of the SOPHU injuries were intentional (74.2%, 121).  Approximately 3% of the SOPHU 
injuries were of unknown intent (3.1%, 5).  During 2007 the numbers of NZHIS 
hospitalisations were split approximately evenly between intentional (30.6%), unintentional 
(34.5%) and unknown (34.9%) exposures. Three-quarters of the SOPHU injuries were 
intentional (74.6%, 88).   
 
 
Ethnicity 
 
Where ethnicity was known (217), the majority of NZHIS hospitalisations were for 
Europeans (75.6%, 164).  Maori had the highest ethnicity-specific rate (388.8 per 100 000 
population, 44).  Ethnicity data was not collected by SOPHU for the emergency department 
notifications.  During 2007 where ethnicity was known (251), the majority of NZHIS 
hospitalisations were for Europeans (84.5%, 212), Europeans also had the highest ethnicity-
specific rate (240.6 per 100 000 population). 
 
 
Substance 
 
The most common NZHIS external cause code was Y11 (Poisoning by and exposure to 
antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere 
classified, undetermined intent) (20.0%, 44), followed by X61 (Intentional self-poisoning by 
and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, 
not elsewhere classified) (10.9%, 24).  During 2007 the most common NZHIS external cause 
code was X61 (14.9%, 38), followed by Y11 (9.4%, 24).  Of the 44 Y11 poisonings during 
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2008, the most common diagnosis codes were T426 (Other antiepileptic and sedative-
hypnotic drugs) (25.0%, 11), T432 (Other and unspecified antidepressants) (18.2%, 8) and 
T424 (Benzodiazepines) (15.9%, 7).  Of the 44 Y11 poisonings, substance was known for 
only 34 hospitalisations, the most common substance was zopiclone (23.5%, 8/34), followed 
by amitriptyline, carbamazepine and citalopram (for each: 11.8%, 4).  During 2007 the 
substance was only known for one hospitalisation, the substance involved was 
carbamazepine.   
 
Where substance class was known (263), the majority of SOPHU notification substances were 
classed as therapeutics (77.6%, 204) followed by chemicals/drugs of abuse (16.0%, 42) and 
household/domestic chemicals (4.6%, 12).  Where substance was known (268), paracetamol 
was the most common substance (12.3% 33), followed by ethanol (10.1%, 27) and codeine 
phosphate (6.7%, 18).  For 2007 where substance class was known (170), the majority of 
SOPHU notification substances were classed as therapeutics (75.9%, 129) followed by 
chemicals/drugs of abuse (14.1%, 24) and household/domestic chemicals (7.6%, 13). Where 
substance was known (170), paracetamol was the most common substance (15.9% 27), 
followed by ethanol (7.6%, 13) and citalopram (5.3%, 9).  
 
4.10. Specific Analyses 
 
Inclusion of several datasets in a comprehensive surveillance system enables comparison of 
data relating to specific public health issues to be investigated.  The resulting picture is 
therefore more representative of the associated burden of injury than would have been 
obtained when examining each dataset separately.  This is illustrated in the following 
examples:  injury in children aged less than five years, poisonings involving paracetamol or 
ethanol, and injuries caused by substances covered by the HSNO Act. 
 
4.10.1. Injuries in Children Aged Less than Five Years 
 
Details on cases aged less than five years are presented in Appendix 1 Table 21 and Table 22.  
ARPHS data are excluded from this analysis since data from Starship Children’s Hospital are 
not received. 
 
In 2008, there were 801 NZHIS poisoning hospitalisations involving children less than five 
years of age (9.3% of total NZHIS poisoning hospitalisations).  The corresponding age-
specific poisoning rate for 2008 was 291.2 per 100 000 population.  As expected, none of the 
NZHIS hospitalisations in this age group were intentional.  The majority of hospitalisations 
were for males (59.6%, 477) and where ethnicity was known (798), the majority were for 
Europeans (58.5%, 467) followed by Maori (28.4%, 227).  Maori had the highest ethnicity-
specific rate (341.7 per 100 000 population), followed by Europeans (315.8 per 100 000 
population).  The most common NZHIS external cause code was X44 (Accidental poisoning 
by and exposure to other and unspecified drugs, medicaments and biological substances) 
(24.2%, 194), followed by X40 (Accidental poisoning by and exposure to nonopioid 
analgesics, antipyretics and antirheumatics) (22.1%, 177).   
 
142 children aged less than five years presented to the emergency department of North 
Shore/Waitakere, Masterton, Wellington, and Invercargill Hospitals.  The majority of 
notifications were for unintentional poisoning (95.1%, 135) and involved more males than 
females (54.9%, 78).  Where ethnicity was known (114), the majority of notifications were for 
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Europeans (74.6%, 85), followed by Maori (13.2%, 15).  Europeans had the highest ethnicity-
specific rate (284.7 per 100 000 population), followed by Pacific Peoples (185.7 per 100 000 
population, 10).  Some of the 142 children had consumed multiple substances.  Of the 143 
known substance occurrences (approximately 69 individual substances) notified from the 
PHUs for children aged less than five years, 28.0% (40) involved paracetamol.  Other 
prominent substances included amoxicillin/clavulanate (4.9%, 7) and diclofenac (3.5%, 5). 
 
4.10.2. Paracetamol Poisonings 
 
Summary demographic data on paracetamol poisonings for 2008 are presented in Appendix 1 
Table 23.  For the emergency department data, paracetamol was either the most common or 
second most common of the identifiable substances. 
 
In total, there were 410 notifications of paracetamol poisoning.  Auckland City Hospital 
reported the highest at 146 (up from 137 reported in 2007), this represents 5.3% of total 
substances for this hospital.  North Shore and Waitakere Hospitals reported a total of 102 
paracetamol poisonings (first year data has been received); this represents 18.1% of the total 
substances for these hospitals.  Masterton Hospital reported 14 paracetamol poisonings (data 
was not received in 2007); this represents 11.2% of the total substances for this hospital.  
Wellington Hospital reported 115 paracetamol poisonings (down from 127 reported in 2007); 
this represents 16.6% of the total substances for this hospital.  Grey Hospital did not report 
any paracetamol poisonings for 2008 (down from 3 reported in 2007).  Invercargill Hospital 
reported 33 paracetamol poisonings (up from 27 reported in 2007); this represents 12.3% of 
the total substances for this hospital.   
 
The majority of the paracetamol notifications for all hospitals were deemed intentional 
(53.4%, 219) (however, 35.6% of the notifications were of unknown intent).  A large 
percentage of the emergency department paracetamol notifications were from the 15-24 year 
age group (44.4%, 182).  Approximately three quarters of the notifications were female 
(74.8%, 306/409) and were of European ethnicity (75.1%, 278/370).   
 
4.10.3. Ethanol Poisonings 
 
Summary demographic data on acute ethanol poisonings for 2008 are presented in 
Appendix 1 Table 24.   
 
There were 322 alcohol hospitalisations (X65, X45 and Y15) throughout New Zealand.  
Hospitalisations were similar for both males (166) and females (156).  The 25-44 years age 
group had the largest percentage of people hospitalised with ethanol poisoning (39.4%, 127), 
whereas, the 15-24 years age group had the highest age-specific rate (5.6 per 100 000 
population, 103).  The number of ethanol poisonings for persons aged less than 18 years (the 
legal drinking age in New Zealand) was 62; this represents 19.3% of the total number of 
ethanol hospitalisations.  There were approximately even numbers of intentional (125) and 
unintentional (117) poisonings.  Where ethnicity was known (319), the majority of 
hospitalisations were for Europeans (66.5%, 212), however, Maori had the highest ethnicity-
specific hospitalisation rate (12.4 per 100 000 population, 70). 
 
In 2008, there were 1460 ethanol notifications (53.0% of the total substances) from Auckland 
City Hospital.  The number of notifications for the remaining five DHBs ranged from one 
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(Grey Hospital) to 228 (North Shore and Waitakere Hospitals), totalling 317.  Ethanol 
consistently appears high up the list for the number of notifications; it was the most common 
substance for North Shore/Waitakere, Auckland City, Masterton Hospitals, second for 
Invercargill Hospital, second equal for Grey Hospital and third for Wellington Hospital. 
 
A number of ethanol poisonings for persons aged less than 18 years (the legal drinking age in 
New Zealand) were recorded; 50 for North Shore/Waitakere Hospitals (21.9% of ethanol 
notifications), 86 for Auckland City Hospital (5.9% of ethanol notifications), 5 for Masterton 
Hospital (20.0% of ethanol notifications), 2 for Wellington Hospital (5.6% of ethanol 
notifications), and 2 for Invercargill Hospital (7.4% of ethanol notifications).  The Grey 
Hospital notification was older than 18 years of age.  The majority of ethanol notifications 
were for males (59.3%, 1053). 
 
 
4.10.4. Injuries Involving HSNO Substances 
 
Summary data on HSNO substance notifications from emergency department are presented in 
Appendix 1 Table 25 and Table 26.   
 
Combined 2008 emergency department data identified 171 emergency department 
notifications involving approximately 51 substances covered by the HSNO Act.  The most 
common HSNO substance reported was carbon monoxide (17.5%, 30), followed by 
hydrocarbons (9.4%, 16) and unspecified chemicals (7.6%, 13).  The majority of notifications 
(46.2%, 79) were the result of unknown exposure and were males (58.5%, 100).  The highest 
age-specific HSNO substance PHU rate was for the 0-4 years age group (26.8 per 100 000 
population, 23), closely followed by the 15-24 years age group (23.6 per 100 000 population, 
46).  Where ethnicity was known (147), the majority were Europeans (60.5%, 89), followed 
by Maori (14.3%, 21).  The highest ethnicity-specific rate was for Maori (20.1 per 100 000 
population), followed by Pacific Peoples (16.7 per 100 000 population, 16). 
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5.  CORONIAL SERVICE OFFICE DATA FOR 2006 AND 2007 
 
Overview 
 
Summary data on CSO deaths for 2006 and 2007 are presented in Appendix 1 Table 28 to 
Table 32.  As of 31 December 2008, the number of deaths attributable to chemical injuries in 
New Zealand for 2006 and 2007 was 196 (4.9 per 100 000 population) and 110 (2.7 per     
100 000 population) respectively.  The number of deaths attributable to chemical injuries for 
2006 and 2007 is generally less than that observed for the years 2003 to 2005 (Figure 15); this 
is not surprising due to timeliness and access issues discussed previously. 
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Figure 15:  Number of New Zealand Chemical Injuries Deaths per Year 
 
 
Intent 
 
Figure 16 illustrates the percentage of chemical injury deaths by intent for 2006 and 2007.  
The graph shows that for both years, the majority of chemical injury deaths were deemed 
intentional (61.2%, 120 deaths for 2006; and 52.7%, 58 deaths for 2007), however, a number 
of deaths were of unknown intent (18.9%, 37 deaths for 2006; and 26.4%, 29 deaths for 
2007). 
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Figure 16:  Percentage of Chemical Injury Deaths by Intent, 2006 and 2007 
 
 
DHB 
 
Figure 17 and Figure 18 illustrate chemical injury mortality data by DHB for both 2006 and 
2007.  In 2006, the greatest number of deaths occurred in Canterbury DHB (38), followed by 
Waitemata (20) and Auckland DHBs (19).  West Coast DHB had the highest rate (9.6 per 
100 000 population, 3), followed by Canterbury DHB (8.1 per 100 000 population, 38).  In 
2007, Canterbury DHB had the highest number of reported deaths (18), followed by Capital 
and Coast DHB (12).  Wanganui DHB had the highest rate (6.4 per 100 000 population, 4), 
followed by Northland DHB (4.7 per 100 000 population, 7).  It is important to note however, 
these rates are often based on a low number of reported deaths and there is often a large 
difference for DHBs in terms in the number of deaths reported between 2006 and 2007.   
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Figure 17:  Number of Chemical Injury Deaths by DHB, 2006 and 2007 
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Figure 18:  Chemical Injury Mortality Rate by DHB, 2006 and 2007 
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In 2006, Waitemata DHB had the greatest number of intentional deaths (16), followed by 
Canterbury DHB (15).  In 2006, 17 DHBs had 50.0% or more of the total deaths attributable 
to intentional exposure.  Canterbury DHB had the greatest number of intentional deaths in 
2007 (11), followed by Northland and Nelson Marlborough DHBs (5 each).  In 2007, 12 
DHBs had 50.0% or more of the total deaths attributable to intentional exposure. 
 
 
Age 
 
In both 2006 and 2007, the highest age-specific mortality rate occurred in the 45-64 years age 
group (7.4 per 100 000 population, 71 and 4.6 per 100 000 population, 44, respectively) 
(Figure 19).  In both years they were marginally ahead of the 25-44 years age group (7.0 per 
100 000 population, 79 and 4.1 per 100 000 population, 47, respectively.  Two children died 
as a result of chemical injury in 2006 (one aged 1-4 years and one aged 5-14 years) and one in 
2007 (aged 5-14 years).   
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Figure 19:  Age-Specific Mortality Rates, 2006 and 2007 
 
 
The proportion of intentional deaths versus unintentional/unknown intent deaths for each age 
group generally increases with increasing age (Figure 20 and Figure 21).  For example, in 
2006 58.3% (14/24) of the deaths for the 15-24 years age group were intentional, this 
compares with 73.7% (14/19) for those aged 65 years and over.  This trend is similar for 2007 
and previous years. 
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Figure 20:  Number of Chemical Injury Deaths by Age Group and Intent, 2006 
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Figure 21:  Number of Chemical Injury Deaths by Age Group and Intent, 2007 
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Sex 
 
For both 2006 and 2007 the majority of chemical injury deaths were for males; 70.9% 
(139/196) and 57.3% (63/110), respectively.  This equates to 2.4 male deaths for every female 
death (139 versus 57) in 2006, and 1.3 male deaths for every female death (63 versus 47) in 
2007. 
 
 
Ethnicity 
 
Where ethnicity was known (191), the majority of chemical injury deaths for 2006 were for 
Europeans (85.3%, 163), followed by Maori (11.0%, 21).  The same pattern was evident for 
2007 (Europeans: 78.3%, 83/106; Maori: 15.1%, 16).  Europeans also had the highest 
ethnicity-specific mortality rate (2006: 6.1 per 100 000 population; 2007: 3.1 per 100 000 
population). 
 
 
Substance  
 
Substance data were similar for 2006 and 2007.  For both years combined, 57.5% (176/306) 
of the deaths involved more than one substance.  Combined results show that just under half 
(45.8%, 132/288) of the substances primarily identified in the deaths (where substance class 
could be assigned) were classed as household/domestic chemicals.  This was followed by 
therapeutics (33.0%, 95) and chemicals/drugs of abuse (18.8%, 54).   
 
The substance that accounts for the majority of household/domestic chemicals substance class 
was carbon monoxide.  Carbon monoxide was the primary substance identified in 40.3% 
(116/288) of deaths for 2006 and 2007 combined.  In particular, it was attributed to 68.5% 
(111/162) of the intentional deaths.  Other primary substances which accounted for a notable 
proportion of the deaths for 2006 and 2007 combined were hydrocarbons (for example 
butane, toluene and petrol) (8.3%, 24), methadone (5.9%, 17) and morphine or heroin (5.6%, 
16).  The leading substances involved in the unintentional deaths were morphine or heroin 
(19.6%, 11/56), methadone (17.9%, 10) and hydrocarbons (16.1%, 9).  Figure 22 shows the 
top primary substances identified that were involved in deaths by intent for 2006 and 2007 
combined.   
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Figure 22:  Top Five Primary Substances Identified in Deaths, 2006 and 2007 combined 
 
 
Primary substances identified for the deaths for these two years which are specifically 
regulated by the HSNO Act included carbon monoxide (116), hydrocarbons (24), cyanide (3), 
chemicals involved with the manufacture of methamphetamine (1), methylated spirits (1), 
paraquat (1), pentachlorophenol (1) and diquat (1).  Where two or more deaths occurred due 
to a hazardous substance (143) (Table 32) the majority were intentional (86.7%, 124), male 
(75.5%, 108), and in the 25-44 years age group (36.4%, 52). 
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6.  CONCLUSIONS 
 
This report has presented comprehensive chemical injury surveillance data for the year 2008.  
It includes national inpatient hospitalisation data (sourced from NZHIS), national spraydrift 
data (sourced from the DriftNet surveillance system), national poison/chemical notifiable 
diseases (sourced from EpiSurv), national poison call data (sourced from the NPC), national 
accident claim data (sourced from ACC), national media analysis and local emergency 
department data for North Shore/Waitakere Hospitals (Waitemata DHB), Auckland City 
Hospital (Auckland DHB), Masterton Hospital (Wairarapa DHB), Wellington Hospital 
(Capital and Coast DHB), Grey Hospital (West Coast DHB) and Invercargill Hospital 
(Southland DHB).  A summary of key statistics for 2008 are detailed in Section 4.2. 
 
In 2004, a comprehensive assemblage of chemical injury data was first presented.  National 
trends across datasets for 2003 and comparison of New Zealand’s mortality figures with 
international results for 2001/2002 were included in the 2003 Annual Report (McDowell et 
al., 2004), and the latter also published in the New Zealand Medical Journal in 2005 
(McDowell, Fowles, & Phillips, 2005).  This years report contains one years worth of local 
emergency department notification data (2008) for all six DHBs (however, it is possible to 
compare this to previous years data as shown illustrated in figures at the overview of each 
section) and two years worth of national CSO data (detailed 2006 and 2007 analysis).  In the 
2005 report analysis was also undertaken using local Hutt DHB emergency department data 
(these data were not available for 2006 to 2008). 
 
As mentioned in Section 3 data from other PHUs/hospitals would be readily and 
appreciatively encompassed into CISS.  While it has been recognised that the most desirable 
means of capturing any notification is via integration with patient management systems, 
resources are currently unavailable to enable this. 
 
This Annual Report is the third year that national chemical/poison related notifiable diseases 
sourced from EpiSurv were included in the CISS and the second year that hazardous 
substances injury data via EpiSurv were included.  It is the intention to continue to 
incorporate this to capture all available chemical/hazardous substances injury data sources. 
 
The 2008 Annual Report is the second time that a more detailed analysis of NPC human 
exposure calls were incorporated in the CISS.  In the past only summarised NPC data was 
available and it was not possible to analyse further.  It is the intention to continue to 
incorporate this in the CISS in the future. 
 
DriftNet data have again been included in this report.  The number of complaints reported by 
PHUs for 2008 was only seven, and the number of complaints reported through DriftNet since 
its implementation in 1998 averages 12 per year for the whole country.  It is apparent that the 
amount of data currently being collected using DriftNet is an under representation of the 
overall number of events.  While we know that the total number of complaints generated by 
the public is much larger that that, only incidents with health impacts fall under the scope of 
DriftNet.  According to a report by Mazzoni (Mazzoni, 2001) there are significant numbers of 
incidents with health effects being reported to councils and not passed on to PHUs: 
 
“…two regional councils forwarded their datasets containing their spray drift incidents over 
the past two years.  Preliminary analysis of both datasets indicates that indeed the reported 
incidents are much higher than what is being captured on Driftnet (over 200 cases total).  In 
both datasets, a number of the spray drift incidents report human exposures and health 
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complaints.  The regional council data however lack the amount of detail and follow up that 
Driftnet would provide.  A comprehensive health impact analysis from these regional council 
datasets is therefore not possible.  This clearly indicates the need for the two agencies (PHSs 
and Regional Councils) to coordinate their efforts in the health sector.  Incidentally one of the 
datasets containing over sixty complaints, some of which indicate human health concerns 
came from a regional council whose PHS had reported no health spray drift complaints in 
Driftnet for either year”. 
 
It has been suggested previously (McDowell, 2004) that the low number of reported 
complaints on DriftNet may be due to: 1) unfamiliarity with the software and/or software 
incompatibility and 2) complaints being directed to the NPC or regional councils rather than 
PHUs.  The regional council’s aspect has been discussed above, and it appears the bulk of 
complaints are being directed there rather than the PHUs or NPC (the NPC only received 29 
spraydrift calls in 2002).  In additions, as ESR is currently accepting the DriftNet data in any 
form from PHUs and no longer requiring the use of DriftNet software program per se, the 
software itself is not a likely reason for the low number of complaints.  Therefore future 
discussion between PHUs and regional councils may improve the referral of spraydrift 
incidents with health impacts to PHUs. 
 
The 2008 Annual Report is the second year that national accident claim data from ACC and a 
national media analysis has been incorporated.  Although it is not possible to capture all ACC 
claims relating to hazardous and chemical injuries or all media articles, the inclusion of this 
data adds another element to the comprehensive CISS.  It is the intention to include these data 
sources in future Annual Reports.   
 
An expanded and more detailed HSNO substance injuries analysis has again been included in 
the 2008 Annual Report.  Analysis of hazardous substances injury by demographics provides 
more useful information and is consistent with other similar analyses in this report. 
 
During 2007 the list of NZHIS hospitalisation ICD-10 external cause codes, which are 
incorporated in the CISS, was reviewed and have been expanded.  The current codes are more 
comprehensive of the range of chemical and hazardous substances injuries that occur and will 
provide a more accurate depiction of the occurrence of such injuries in New Zealand.  The 
expanded list will therefore be capturing more injuries and for this reason, the numbers in 
2008 can be directly compared to the numbers for 2007 but should not be directly compared 
to the numbers reported previous to this.      
 
The small number of cases involved with some of the datasets presented in this report, 
particularly the CSO data, requires caution when interpreting figures, especially rates.  A 
further limitation of the data presented in this report is the incomplete nature of the CSO data 
for 2007.  As the timing of the reports filed at the CSO can vary by coroner, comparisons 
across DHBs must be done with care.  While intent is most reliable for deaths (determined by 
the coroner), intent associated with PHU notifications is less robust.  For the West Coast and 
Southland notification data presented in this report, which did not have intent specifically 
assigned, cases reported as overdoses have been classed as intentional, with any other, for 
example ingestion or inhalation, have been classed as unintentional. 
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APPENDIX 1 
 
Table 6: National Chemical Injury Data from NZHIS, PHU and DriftNet by DHB, 2008 
NZHIS PHU DriftNet 
Admitted Patients Notifications Complaints DHB 
No. Rate
1
 No. Rate
1
 No. 
Northland 308 207.5   1 
Waitemata 1159 240.7 672 139.5 0 
Auckland 921 227.6 2017 498.5 0 
Counties Manukau 1016 234.6   0 
Waikato 532 156.9   0 
Lakes 271 275.5   0 
Bay of Plenty 424 217.5   2 
Tairawhiti 65 146.3   0 
Taranaki 171 163.9   0 
Hawke's Bay 234 157.8   3 
Wanganui 170 273.4   0 
MidCentral 396 249.3   0 
Hutt 181 133.0   0 
Capital and Coast 215 80.6 563 211.1 0 
Wairarapa 120 310.4 92 238.0 0 
Nelson 
Marlborough 
285 219.1   0 
West Coast 46 146.8 5 16.0 1 
Canterbury 1051 225.3   0 
South Canterbury 88 163.1   0 
Otago 479 267.0   0 
Southland 220 205.9 163 152.6 0 
Area Outside DHB 219     
National 8571 212.8   7 
 
1  Rate calculated using 2006 Census data and expressed as per 100 000 population.  Caution advised when interpreting rates based  
on counts less than ten. 
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Table 7:  National Chemical Injury Demographic Data from NZHIS, 2008 
NZHIS (Admitted 
Patients) Demographics 
No. Rate
1
 %
2
 
Intentional 4177 103.7 48.7 
Unintentional 2692 66.8 31.4 
Assault 10 0.2 0.1 
Legal 2 0.0 0.0 
Indeterminate or 
Intent 
Unknown Intent 
1690 42.0 19.7 
0-4 801 291.2 9.3 
5-14 380 64.1 4.4 
15-24 2109 369.2 24.6 
25-44 2853 251.5 33.3 
45-64 1744 181.8 20.3 
Age Group 
65+ 684 138.0 8.0 
Female 4946 239.8 57.7 
Male 3624 184.4 42.3 Sex 
Unknown 1   
European 6042 224.3 71.3 
Maori 1447 256.0 17.1 
Pacific Peoples 394 174.1 4.6 
Asian 377 110.6 4.4 
Other 220  2.6 
Ethnicity 
Unknown 91   
National  8571 212.8  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based  
on counts less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 8:  Waitemata DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU 
(Admitted 
Patients) 
Notifications Demographics 
No. Rate
1
 %
2
 No. Rate
1
 %
2
 
Intentional 592 122.9 51.1 
 
298 61.9 44.3 
Unintentional 386 80.1 33.3 
 
103 21.4 15.3 
Assault 1 0.2 0.1    
Legal 0 0.0 0.0    
Indeterminate or 
Intent 
Unknown Intent 
180 37.4 15.5 271 56.3 40.3 
0-4 106 322.3 9.1 66 200.7 9.8 
5-14 46 64.2 4.0 21 29.3 3.1 
15-24 300 443.1 25.9 239 353.0 35.6 
25-44 369 257.8 31.8 195 136.2 29.0 
45-64 252 222.5 21.7 130 114.8 19.3 
Age 
Group 
65+ 86 162.4 7.4 21 39.7 3.1 
Female 660 267.0 56.9 392 158.6 58.4 
Male 499 212.9 43.1 279 119.0 41.6 Sex 
Unknown 0   1     
European 855 271.3 74.4 515 163.4 78.4 
Maori 135 314.9 11.7 61 142.3 9.3 
Pacific Peoples 61 200.6 5.3 31 101.9 4.7 
Asian 70 105.7 6.1 37 55.8 5.6 
Other 28  2.4 13   2.0 
Ethnicity 
Unknown 10   15     
Overall 1159 240.7  672 139.5  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 9:  Auckland DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU 
(Admitted 
Patients) 
Notifications Demographics 
No. Rate
1
 %
2
 No. Rate
1
 %
2
 
Intentional 497 122.8 54.0 68 16.8 3.4 
Unintentional 333 82.3 36.2 67 16.6 3.3 
Assault 2 0.5 0.2    
Legal 0 0.0 0.0    
Indeterminate or 
Intent 
Unknown Intent 
89 22.0 9.7 1882 465.2 93.3 
0-4 75 287.9 8.1 0 0.0 0.0 
5-14 29 58.0 3.1 0 0.0 0.0 
15-24 241 358.4 26.2 794 1180.9 39.4 
25-44 337 247.5 36.6 743 545.6 36.9 
45-64 178 206.2 19.3 394 456.4 19.6 
65+ 61 157.3 6.6 83 214.0 4.1 
Age 
Group 
Unknown 0   3   
Female 515 248.3 55.9 892 430.1 44.5 
Male 406 205.9 44.1 1112 563.9 55.5 Sex 
Unknown 0   13   
European 581 278.1 64.3 1339 641.0 68.7 
Maori 108 361.9 11.9 206 690.3 10.6 
Pacific Peoples 77 169.0 8.5 168 368.8 8.6 
Asian 103 112.5 11.4 203 221.7 10.4 
Other 35  3.9 32  1.6 
Ethnicity 
Unknown 17   69   
Overall 921 227.6  2017 498.5  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 10:  Wairarapa DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU  
(Admitted Patients) Notifications Demographics 
No. Rate
1
 %
2
 No. Rate
1
 %
2
 
Intentional 66 170.7 55.0 
 
57 147.5 62.0 
Unintentional 26 67.3 21.7 
 
25 64.7 27.2 
Assault 0 0.0 0.0    
Legal 0 0.0 0.0    
Indeterminate or  
Intent 
Unknown Intent 
28 72.4 23.3 10 25.9 10.9 
0-4 12 492.0 10.0 14 574.0 15.2 
5-14 11 192.3 9.2 10 174.8 10.9 
15-24 33 780.1 27.5 18 425.5 19.6 
25-44 31 341.1 25.8 31 341.1 33.7 
45-64 29 267.5 24.2 18 166.0 19.6 
Age 
Group 
65+ 4 63.1 3.3 1 15.8 1.1 
Female 66 332.3 55.0 56 281.9 60.9 
Sex 
Male 54 287.3 45.0 36 191.6 39.1 
European 91 296.1 75.8 56 182.2 76.7 
Maori 25 455.2 20.8 15 273.1 20.5 
Pacific Peoples 1 159.7 0.8 0 0.0 0.0 
Asian 2 402.4 1.7 0 0.0 0.0 
Other 1  0.8 2  2.7 
Ethnicity 
Unknown 0   19   
Overall 120 310.4  92 238.0  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 11:  Capital and Coast DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU  
(Admitted Patients) Notifications Demographics 
No. Rate
1
 %
2
 No. Rate
1
 %
2
 
Intentional 115 43.1 53.5 415 155.6 73.7 
Unintentional 64 24.0 29.8 106 39.8 18.8 
Assault 0 0.0 0.0    
Legal 0 0.0 0.0    
Indeterminate or  
Intent 
Unknown Intent 
36 13.5 16.7 42 15.8 7.5 
0-4 24 137.0 11.2 39 222.7 6.9 
5-14 10 29.1 4.7 11 32.0 2.0 
15-24 60 141.6 27.9 213 502.8 37.8 
25-44 64 75.0 29.8 184 215.7 32.7 
45-64 39 66.1 18.1 94 159.4 16.7 
Age 
Group 
65+ 18 64.0 8.4 22 78.3 3.9 
Female 137 99.2 63.7 388 280.9 68.9 
Sex 
Male 78 60.7 36.3 175 136.2 31.1 
European 145 79.5 69.4 410 224.8 75.8 
Maori 31 117.0 14.8 68 256.6 12.6 
Pacific Peoples 16 84.2 7.7 22 115.7 4.1 
Asian 7 28.3 3.3 21 84.9 3.9 
Other 10  4.8 20  3.7 
Ethnicity 
Unknown 6   22   
Overall 215 80.6  563 211.1  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 12:  West Coast DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU 
(Admitted Patients) Notifications Demographics 
No. Rate
1
 %
2
 No. Rate
1
 %
2
 
Intentional 26 83.0 56.5 2 6.4 40.0 
Unintentional 11 35.1 23.9 3 9.6 60.0 
Assault 0 0.0 0.0    
Legal 0 0.0 0.0    
Indeterminate or 
Intent 
Unknown Intent 
9 28.7 19.6 0 0.0 0.0 
0-4 3 158.2 6.5 0 0.0 0.0 
5-14 3 66.7 6.5 0 0.0 0.0 
15-24 10 295.3 21.7 1 29.5 20.0 
25-44 15 179.2 32.6 3 35.8 60.0 
45-64 12 136.1 26.1 1 11.3 20.0 
Age 
Group 
65+ 3 68.7 6.5 0 0.0 0.0 
Female 24 155.6 52.2 4 26.0 80.0 
Sex 
Male 22 138.3 47.8 1 6.3 20.0 
European 40 149.9 88.9 2 7.5 100.0 
Maori 4 137.5 8.9 0 0.0 0.0 
Pacific Peoples 1 518.1 2.2 0 0.0 0.0 
Asian 0 0.0 0.0 0 0.0 0.0 
Other 0  0.0 0  0.0 
Ethnicity 
Unknown 1   3   
Overall 46 146.8  5 16.0  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 13:  Southland DHB Chemical Injury Demographic Data from NZHIS, and PHU, 2008 
NZHIS PHU 
(Admitted Patients) Notifications Demographics 
No. Rate
2
 %
3
 No. Rate
2
 %
3
 
Intentional 64 59.9 29.1 121 113.3 74.2 
Unintentional 64 59.9 29.1 37 34.6 22.7 
Assault 0 0.0 0.0    
Legal 0 0.0 0.0    
Indeterminate or 
Intent 
Unknown Intent 
92 86.1 41.8 5 4.7 3.1 
0-4 32 463.0 14.5 23 332.8 14.1 
5-14 11 73.9 5.0 8 53.7 4.9 
15-24 62 451.3 28.2 55 400.4 33.7 
25-44 63 202.4 28.6 62 199.2 38.0 
45-64 36 136.7 16.4 14 53.2 8.6 
Age 
Group 
65+ 16 115.7 7.3 1 7.2 0.6 
Female 119 222.5 54.1 107 200.1 65.6 
Sex 
Male 101 189.3 45.9 56 105.0 34.4 
European 164 186.1 75.6 
Maori 44 388.8 20.3 
Pacific Peoples 1 83.2 0.5 
Asian 2 103.0 0.9 
Other 6  2.8 
Ethnicity 
Unknown 3   
Ethnicity data not 
collected 
Overall 220 205.9  163 152.6  
 
1  Rate calculated using 2006 Census data and expressed per 100 000 population.  Caution advised when interpreting rates based on counts 
less than ten. 
2  Proportion (%) of total cases (for respective data source) where demographic (age group/sex/ethnicity) was known. 
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Table 26:  HSNO Substances Injury Data from PHU, 2008 
PHU 
Notifications Demographics 
No. Rate %
1
 
Intentional 37 2.8 21.6 
Unintentional 55 4.2 32.2 
Indeterminate or  
Intent 
Unknown Intent 
79 6.1 46.2 
0-4 23 26.8 13.5 
5-14 1 0.6 0.6 
15-24 46 23.6 26.9 
25-44 58 14.3 33.9 
45-64 38 12.8 22.2 
Age 
Group 
65+ 5 3.6 2.9 
Female 71 10.7 41.5 
Sex 
Male 100 15.8 58.5 
European 89 12.1 60.5 
Maori 21 20.1 14.3 
Pacific Peoples 16 16.7 10.9 
Asian 14 7.6 9.5 
Other 7  4.8 
Ethnicity 
Unknown 24   
Overall 171 13.2  
 
1  Proportion (%) of total HSNO substance poisonings where demographic (age/sex/ethnicity) was known. 
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Table 27:  Injury Claim Data from ACC, 2008 
ICD10 Primary Diagnosis Codes 
Demographics 
J61 J68
1
 L2
2
 T3
3
 T5
4
 T70.3 T96 T97 
0-4 ≤3 0 112 60 0 ≤3 
5-14 5 0 10 22 0 0 
15-24 8 0 22 54 0 0 
25-44 11 4 34 74 5 ≤3 
45-64 9 ≤3 18 34 ≤3 ≤3 
Age 
group 
65+ ≤3 ≤3 ≤3 7 ≤3 ≤3 
Female 14 4 101 114 ≤3 ≤3 
Sex 
Male 23 4 97 137 5 ≤3 
European 16 4 141 161 5 ≤3 
Maori 7 0 36 42 ≤3 ≤3 
Pacific Peoples 6 ≤3 ≤3 6 0 0 
Asian ≤3 ≤3 6 10 0 0 
Other 4 0 9 16 ≤3 ≤3 
Ethnicity 
Unknown 
 
≤3 ≤3 4 15 0 0 
 
Overall
5
 0 37 8 198 251 7 5 0 
 
1  J68.0 – J68.3 
2 L23.0 – L23.5, L23.7, L23.8, L24.0–L24.5, L24.7, L24.8, L25.0–L25.3, L25.5, L23.8, L27.0, L27.1 
3 T36.0 – T50.9 
4 T51.0 – T65.9 
5 Where counts are equal to 3, this could reflect a number between 1 and 3 and thus the overall total may not be the actual total of cases. 
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Table 28:  CSO Chemical Injury Data by DHB, 2006 and 2007 
2006 2007 DHB 
  “A” “I” “U” Total Rate1 “A” “I” “U” Total Rate1 
Northland 1 7 0 8 5.4 1 5 1 7 4.7 
Waitemata 4 16 0 20 4.2 2 4 2 8 1.7 
Auckland 4 9 6 19 4.7 1 3 4 8 2.0 
Counties Manukau 2 12 4 18 4.2 2 4 3 9 2.1 
Waikato 3 11 3 17 5.0 2 1 3 6 1.8 
Lakes 1 2 0 3 3.1 0 2 0 2 2.0 
Bay of Plenty 0 6 0 6 3.1 0 4 1 5 2.6 
Tairawhiti 0 1 0 1 2.3 0 0 0 0 0.0 
Taranaki 1 3 2 6 5.8 0 2 1 3 2.9 
Hawke's Bay 0 3 1 4 2.7 1 1 0 2 1.3 
Whanganui 0 1 0 1 1.6 1 2 1 4 6.4 
MidCentral 3 7 2 12 7.6 1 4 2 7 4.4 
Hutt 0 2 1 3 2.2 1 1 1 3 2.2 
Capital and Coast 1 7 2 10 3.8 3 3 6 12 4.5 
Wairarapa 0 0 1 1 2.6 0 0 0 0 0.0 
Nelson Marlborough 1 5 1 7 5.4 0 5 1 6 4.6 
West Coast 0 2 1 3 9.6 0 0 0 0 0.0 
Canterbury 15 15 8 38 8.1 4 11 3 18 3.9 
South Canterbury 0 1 1 2 3.7 1 0 0 1 1.9 
Otago 3 5 3 11 6.1 3 4 0 7 3.9 
Southland 0 5 1 6 5.6 0 2 0 2 1.9 
National 39 120 37 196 4.9 23 58 29 110 2.7 
1  Rate calculated using 2006 Census data and expressed per 100 000 population. Caution advised when interpreting rates based on counts 
less than ten. 
“A” = Accidental or Unintentional, “I” = Intentional and “U” = Unknown Intent  
 
Table 29:  CSO Chemical Injury Demographic Data, 2006 and 2007 
2006 2007 
Demographics 
“A” “I” “U” Total Rate
1 
“A” “I
” 
“U” Total Rate
1 
0-4 0 0 1 1 0.4 0 0 0 0 0.0 
5-14 1 0 0 1 0.2 0 0 1 1 0.2 
15-24 7 14 3 24 4.2 1 4 4 9 1.6 
25-44 17 47 15 79 7.0 14 23 10 47 4.1 
45-64 12 44 15 71 7.4 6 25 13 44 4.6 
65+ 2 14 3 19 3.8 2 6 1 9 1.8 
Age 
Group 
Unknown 0 1 0 1  0 0 0 0  
Female 9 37 11 57 2.8 15 23 9 47 2.3 
Sex 
Male 30 83 26 139 7.1 8 35 20 63 3.2 
European 31 103 29 163 6.1 17 45 21 83 3.1 
Maori 7 8 6 21 3.7 3 8 5 16 2.8 
Pacific Peoples 1 2 0 3 1.3 1 0 0 1 0.4 
Asian 0 4 0 4 1.2 0 1 1 2 0.6 
Other 0 0 0 0  2 2 0 4  
Ethnicity 
Unknown 0 3 2 5  0 2 2 4  
National 39 120 37 196 4.9 23 58 29 110 2.7 
1
 Rate calculated using 2006 Census data and expressed per 100 000 population. Caution advised when interpreting rates based on counts 
less than ten. 
“A” = Accidental or Unintentional, “I” = Intentional and “U” = Unknown Intent 
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Table 32:  Demographics for CSO HSNO Substances, 2006 and 2007 Combined 
Note: Where count of substance is not greater than one, details are not included in the table to protect privacy. Relevant 
substances include: clandestine methamphetamine laboratory chemicals, methylated spirits, paraquat, pentachlorophenol and 
diquat. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Hydrocarbon includes petrol, turpentine, LPG, butane etc.  
2 
Primary substance identified as involved in death 
HSNO Substances 
Characteristics Carbon 
Monoxide Hydrocarbon
1
 Cyanide 
Number (primary 
substance2) 
116 24 3 
DHB    
  Northland 9 1 0 
  Waitemata 13 3 0 
  Auckland 4 2 0 
  Counties Manukau 10 3 1 
  Waikato 12 1 1 
  Lakes 4 0 0 
  Bay of Plenty 5 2 0 
  Tairawhiti 1 0 0 
  Taranaki 1 1 1 
  Hawke's Bay 2 0 0 
  Whanganui 0 0 0 
  MidCentral 11 1 0 
  Hutt 2 1 0 
  Capital and Coast 5 0 0 
  Wairarapa 0 0 0 
  Nelson Marlborough 6 1 0 
  West Coast 1 1 0 
  Canterbury 21 6 0 
  South Canterbury 0 0 0 
  Otago 5 1 0 
  Southland 4 0 0 
Intent    
  Intentional 111 11 2 
  Unintentional 2 9 0 
  Indeterminate/Unknown 3 4 1 
Age    
  0-4 0 1 0 
  5-14 0 2 0 
  15-24 12 7 0 
  25-44 45 6 1 
  45-64 43 4 1 
  65+ 15 4 1 
  Unknown 1 0 0 
Sex    
  Female 27 7 1 
  Male 89 17 2 
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APPENDIX 2 
 
Chemical category working definitions with examples: 
 
• Therapeutics: Prescription or non-prescription drugs are included in this category 
even if they are used inappropriately (i.e. deliberately with intent to injure, or with 
intent to abuse but not injure). 
 
• Agrichemicals: Includes pesticides and licensed veterinary medicines.  
 
• Industrial chemicals:  For instance, solvents and caustic chemicals used in an 
industrial or occupational setting.  The same chemicals may also be found in the home 
(for example, isopropyl alcohol), and be covered under household/domestic. 
 
• Household/domestic chemicals: cleansers, detergents, methylated spirits (accidents 
only), carbon monoxide, etc... 
 
• Chemicals/drugs of abuse: Includes chemicals of addiction.  Methylated spirits, 
ethanol, methadone, heroin, cocaine, methamphetamine, fantasy, ecstasy, etc… 
 
• Herbal remedies/dietary supplements:  vitamins, natural product remedies, etc… 
 
• Plants:  garden plants 
 
• Bites/Stings: spider bites, bee stings 
 
• Other/Unknown 
 
 
 
